TW201211693A - Curable composition - Google Patents
Curable composition Download PDFInfo
- Publication number
- TW201211693A TW201211693A TW100119169A TW100119169A TW201211693A TW 201211693 A TW201211693 A TW 201211693A TW 100119169 A TW100119169 A TW 100119169A TW 100119169 A TW100119169 A TW 100119169A TW 201211693 A TW201211693 A TW 201211693A
- Authority
- TW
- Taiwan
- Prior art keywords
- parts
- acrylate
- curable composition
- active energy
- energy ray
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 152
- 150000001875 compounds Chemical class 0.000 claims abstract description 56
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims abstract description 42
- 239000012965 benzophenone Substances 0.000 claims abstract description 42
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims abstract description 41
- 125000003118 aryl group Chemical group 0.000 claims abstract description 32
- 239000012948 isocyanate Substances 0.000 claims abstract description 18
- 150000002513 isocyanates Chemical class 0.000 claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 8
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 8
- -1 fluorenylmethyl Chemical group 0.000 claims description 47
- 239000000126 substance Substances 0.000 claims description 35
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- KCTAWXVAICEBSD-UHFFFAOYSA-N prop-2-enoyloxy prop-2-eneperoxoate Chemical compound C=CC(=O)OOOC(=O)C=C KCTAWXVAICEBSD-UHFFFAOYSA-N 0.000 claims description 15
- 239000003999 initiator Substances 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- 229920001610 polycaprolactone Polymers 0.000 claims description 9
- 239000004632 polycaprolactone Substances 0.000 claims description 9
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine group Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 6
- 125000006267 biphenyl group Chemical group 0.000 claims description 3
- 239000004848 polyfunctional curative Substances 0.000 claims description 3
- 125000000524 functional group Chemical group 0.000 claims description 2
- PDNPNPYPVCZSTH-UHFFFAOYSA-N NC(=O)OCC.C(C=C)(=O)OS Chemical compound NC(=O)OCC.C(C=C)(=O)OS PDNPNPYPVCZSTH-UHFFFAOYSA-N 0.000 claims 1
- 239000004593 Epoxy Substances 0.000 abstract description 11
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 abstract description 8
- 125000000217 alkyl group Polymers 0.000 abstract description 2
- 150000003673 urethanes Polymers 0.000 abstract description 2
- UHESRSKEBRADOO-UHFFFAOYSA-N ethyl carbamate;prop-2-enoic acid Chemical compound OC(=O)C=C.CCOC(N)=O UHESRSKEBRADOO-UHFFFAOYSA-N 0.000 description 58
- 230000015572 biosynthetic process Effects 0.000 description 56
- 238000003786 synthesis reaction Methods 0.000 description 56
- 229920002799 BoPET Polymers 0.000 description 39
- 239000011248 coating agent Substances 0.000 description 26
- 239000000052 vinegar Substances 0.000 description 26
- 235000021419 vinegar Nutrition 0.000 description 26
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 24
- 229910052707 ruthenium Inorganic materials 0.000 description 24
- 239000012956 1-hydroxycyclohexylphenyl-ketone Substances 0.000 description 20
- MQDJYUACMFCOFT-UHFFFAOYSA-N bis[2-(1-hydroxycyclohexyl)phenyl]methanone Chemical compound C=1C=CC=C(C(=O)C=2C(=CC=CC=2)C2(O)CCCCC2)C=1C1(O)CCCCC1 MQDJYUACMFCOFT-UHFFFAOYSA-N 0.000 description 20
- 238000000576 coating method Methods 0.000 description 17
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 15
- 239000003822 epoxy resin Substances 0.000 description 15
- 229920000647 polyepoxide Polymers 0.000 description 15
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 13
- 239000000463 material Substances 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 11
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 10
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Polymers CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 10
- GCTPMLUUWLLESL-UHFFFAOYSA-N benzyl prop-2-enoate Chemical compound C=CC(=O)OCC1=CC=CC=C1 GCTPMLUUWLLESL-UHFFFAOYSA-N 0.000 description 10
- 230000006378 damage Effects 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 9
- 239000000178 monomer Substances 0.000 description 9
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 8
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 8
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 8
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 8
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical group O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 6
- 101000720524 Gordonia sp. (strain TY-5) Acetone monooxygenase (methyl acetate-forming) Proteins 0.000 description 6
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 6
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 6
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 6
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 5
- 239000004925 Acrylic resin Substances 0.000 description 5
- 229920000178 Acrylic resin Polymers 0.000 description 5
- 235000010290 biphenyl Nutrition 0.000 description 5
- 239000004305 biphenyl Substances 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- 125000004386 diacrylate group Chemical group 0.000 description 5
- 125000005442 diisocyanate group Chemical group 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- WXPWZZHELZEVPO-UHFFFAOYSA-N (4-methylphenyl)-phenylmethanone Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=CC=C1 WXPWZZHELZEVPO-UHFFFAOYSA-N 0.000 description 4
- GJYCVCVHRSWLNY-UHFFFAOYSA-N 2-butylphenol Chemical compound CCCCC1=CC=CC=C1O GJYCVCVHRSWLNY-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 4
- KYIKRXIYLAGAKQ-UHFFFAOYSA-N abcn Chemical compound C1CCCCC1(C#N)N=NC1(C#N)CCCCC1 KYIKRXIYLAGAKQ-UHFFFAOYSA-N 0.000 description 4
- MWZGUEWUOKSFNL-UHFFFAOYSA-N benzoic acid;styrene Chemical compound C=CC1=CC=CC=C1.OC(=O)C1=CC=CC=C1 MWZGUEWUOKSFNL-UHFFFAOYSA-N 0.000 description 4
- 150000008366 benzophenones Chemical class 0.000 description 4
- 238000010894 electron beam technology Methods 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 235000019260 propionic acid Nutrition 0.000 description 4
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- HHQAGBQXOWLTLL-UHFFFAOYSA-N (2-hydroxy-3-phenoxypropyl) prop-2-enoate Chemical compound C=CC(=O)OCC(O)COC1=CC=CC=C1 HHQAGBQXOWLTLL-UHFFFAOYSA-N 0.000 description 3
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 3
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical group C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 3
- QWAQAOYPPUKJQG-UHFFFAOYSA-N C(C1=CC=CC=C1)(=O)O.C(C=1C(C(=O)O)=CC=CC1)(=O)OC Chemical compound C(C1=CC=CC=C1)(=O)O.C(C=1C(C(=O)O)=CC=CC1)(=O)OC QWAQAOYPPUKJQG-UHFFFAOYSA-N 0.000 description 3
- MBLMGNKWCVCKCE-UHFFFAOYSA-N C(C=1C(C(=O)O)=CC=CC1)(=O)ON.C(C=C)(=O)O Chemical compound C(C=1C(C(=O)O)=CC=CC1)(=O)ON.C(C=C)(=O)O MBLMGNKWCVCKCE-UHFFFAOYSA-N 0.000 description 3
- 102100020870 La-related protein 6 Human genes 0.000 description 3
- 108050008265 La-related protein 6 Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 3
- MPIAGWXWVAHQBB-UHFFFAOYSA-N [3-prop-2-enoyloxy-2-[[3-prop-2-enoyloxy-2,2-bis(prop-2-enoyloxymethyl)propoxy]methyl]-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C MPIAGWXWVAHQBB-UHFFFAOYSA-N 0.000 description 3
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 3
- 210000003298 dental enamel Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000004811 fluoropolymer Substances 0.000 description 3
- 229920002313 fluoropolymer Polymers 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- UPGATMBHQQONPH-UHFFFAOYSA-N 2-aminooxycarbonylbenzoic acid Chemical class NOC(=O)C1=CC=CC=C1C(O)=O UPGATMBHQQONPH-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- OWIKHYCFFJSOEH-UHFFFAOYSA-N Isocyanic acid Chemical compound N=C=O OWIKHYCFFJSOEH-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 125000003277 amino group Polymers 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 2
- 229910052797 bismuth Inorganic materials 0.000 description 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 2
- PXKLMJQFEQBVLD-UHFFFAOYSA-N bisphenol F Chemical compound C1=CC(O)=CC=C1CC1=CC=C(O)C=C1 PXKLMJQFEQBVLD-UHFFFAOYSA-N 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbamic acid group Polymers C(N)(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical compound CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 description 2
- 150000002923 oximes Chemical class 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- GRDGBWVSVMLKBV-UHFFFAOYSA-N (2-amino-5-nitrophenyl)-(2-chlorophenyl)methanone Chemical compound NC1=CC=C([N+]([O-])=O)C=C1C(=O)C1=CC=CC=C1Cl GRDGBWVSVMLKBV-UHFFFAOYSA-N 0.000 description 1
- CSUUDNFYSFENAE-UHFFFAOYSA-N (2-methoxyphenyl)-phenylmethanone Chemical compound COC1=CC=CC=C1C(=O)C1=CC=CC=C1 CSUUDNFYSFENAE-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- XMKLTEGSALONPH-UHFFFAOYSA-N 1,2,4,5-tetrazinane-3,6-dione Chemical compound O=C1NNC(=O)NN1 XMKLTEGSALONPH-UHFFFAOYSA-N 0.000 description 1
- QWUWMCYKGHVNAV-UHFFFAOYSA-N 1,2-dihydrostilbene Chemical compound C=1C=CC=CC=1CCC1=CC=CC=C1 QWUWMCYKGHVNAV-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- JOFQXPUKJJQCPW-UHFFFAOYSA-N 1-methyl-1-propylhydrazine Chemical compound CCCN(C)N JOFQXPUKJJQCPW-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- INQDDHNZXOAFFD-UHFFFAOYSA-N 2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethyl prop-2-enoate Chemical group C=CC(=O)OCCOCCOCCOC(=O)C=C INQDDHNZXOAFFD-UHFFFAOYSA-N 0.000 description 1
- YMFRTBYULFBHOJ-UHFFFAOYSA-N 2-[2-[2-(2-oxocyclohexyl)benzoyl]phenyl]cyclohexan-1-one Chemical compound O=C1C(CCCC1)C1=C(C=CC=C1)C(=O)C1=C(C=CC=C1)C1C(CCCC1)=O YMFRTBYULFBHOJ-UHFFFAOYSA-N 0.000 description 1
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 1
- RESDJAQXNNEBIQ-UHFFFAOYSA-N 2-ethoxyhexanoic acid Chemical compound CCCCC(C(O)=O)OCC RESDJAQXNNEBIQ-UHFFFAOYSA-N 0.000 description 1
- WVRHNZGZWMKMNE-UHFFFAOYSA-N 2-hydroxy-1-[2-(2-methylpropyl)phenyl]-2-phenylethanone Chemical compound CC(C)CC1=CC=CC=C1C(=O)C(O)C1=CC=CC=C1 WVRHNZGZWMKMNE-UHFFFAOYSA-N 0.000 description 1
- NACPTFCBIGBTSJ-UHFFFAOYSA-N 2-hydroxy-2-phenyl-1-(2-propan-2-ylphenyl)ethanone Chemical compound CC(C)C1=CC=CC=C1C(=O)C(O)C1=CC=CC=C1 NACPTFCBIGBTSJ-UHFFFAOYSA-N 0.000 description 1
- BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical compound CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 1
- OELQSSWXRGADDE-UHFFFAOYSA-N 2-methylprop-2-eneperoxoic acid Polymers CC(=C)C(=O)OO OELQSSWXRGADDE-UHFFFAOYSA-N 0.000 description 1
- RZVINYQDSSQUKO-UHFFFAOYSA-N 2-phenoxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC1=CC=CC=C1 RZVINYQDSSQUKO-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ZLWGPFAPFZOSIO-UHFFFAOYSA-N 3,3-bis(1H-inden-1-yl)prop-2-enoic acid Chemical compound C1(C=CC2=CC=CC=C12)C(=CC(=O)O)C1C=CC2=CC=CC=C12 ZLWGPFAPFZOSIO-UHFFFAOYSA-N 0.000 description 1
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 description 1
- IFEHRXMEQSKWNE-UHFFFAOYSA-N 3-methyl-2-propylbenzoic acid Chemical compound CCCC1=C(C)C=CC=C1C(O)=O IFEHRXMEQSKWNE-UHFFFAOYSA-N 0.000 description 1
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical compound C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 description 1
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 description 1
- FVCSARBUZVPSQF-UHFFFAOYSA-N 5-(2,4-dioxooxolan-3-yl)-7-methyl-3a,4,5,7a-tetrahydro-2-benzofuran-1,3-dione Chemical compound C1C(C(OC2=O)=O)C2C(C)=CC1C1C(=O)COC1=O FVCSARBUZVPSQF-UHFFFAOYSA-N 0.000 description 1
- ZMFWEWMHABZQNB-UHFFFAOYSA-N 6-acetyloxyhexyl acetate Chemical compound CC(=O)OCCCCCCOC(C)=O ZMFWEWMHABZQNB-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- IBPADELTPKRSCQ-UHFFFAOYSA-N 9h-fluoren-1-yl prop-2-enoate Chemical compound C1C2=CC=CC=C2C2=C1C(OC(=O)C=C)=CC=C2 IBPADELTPKRSCQ-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 229930185605 Bisphenol Natural products 0.000 description 1
- NDKYEUQMPZIGFN-UHFFFAOYSA-N Butyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCC NDKYEUQMPZIGFN-UHFFFAOYSA-N 0.000 description 1
- VJQVYOWJNOGOIO-UHFFFAOYSA-N C(C)[C-]1NC=CC1=O Chemical compound C(C)[C-]1NC=CC1=O VJQVYOWJNOGOIO-UHFFFAOYSA-N 0.000 description 1
- MVSZNNBDIOGRHE-UHFFFAOYSA-N C(CC(=O)C)(=O)O.NC1=C(C(C(=O)O)=CC=C1)C(=O)O Chemical compound C(CC(=O)C)(=O)O.NC1=C(C(C(=O)O)=CC=C1)C(=O)O MVSZNNBDIOGRHE-UHFFFAOYSA-N 0.000 description 1
- FQJRBHUZUNBPAR-UHFFFAOYSA-N C(CCCCCCCCC)C1=C2NC(=C1)C=C1C=CC(=N1)C=C1C=CC(N1)=CC=1C=CC(N1)=C2.C=CC Chemical compound C(CCCCCCCCC)C1=C2NC(=C1)C=C1C=CC(=N1)C=C1C=CC(N1)=CC=1C=CC(N1)=C2.C=CC FQJRBHUZUNBPAR-UHFFFAOYSA-N 0.000 description 1
- BGEHDVPRGAKCBC-UHFFFAOYSA-N CC(C)C(O)=O.OC(=O)C(F)(F)F Chemical compound CC(C)C(O)=O.OC(=O)C(F)(F)F BGEHDVPRGAKCBC-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- UXMQORVHJMUQFD-UHFFFAOYSA-N Heptanophenone Chemical compound CCCCCCC(=O)C1=CC=CC=C1 UXMQORVHJMUQFD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- HJOVHMDZYOCNQW-UHFFFAOYSA-N Isophorone Natural products CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 1
- NQSMEZJWJJVYOI-UHFFFAOYSA-N Methyl 2-benzoylbenzoate Chemical compound COC(=O)C1=CC=CC=C1C(=O)C1=CC=CC=C1 NQSMEZJWJJVYOI-UHFFFAOYSA-N 0.000 description 1
- CRZQGDNQQAALAY-UHFFFAOYSA-N Methyl benzeneacetate Chemical compound COC(=O)CC1=CC=CC=C1 CRZQGDNQQAALAY-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical group O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- BDAHDQGVJHDLHQ-UHFFFAOYSA-N [2-(1-hydroxycyclohexyl)phenyl]-phenylmethanone Chemical compound C=1C=CC=C(C(=O)C=2C=CC=CC=2)C=1C1(O)CCCCC1 BDAHDQGVJHDLHQ-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- GJAYYEWRFJQMQK-UHFFFAOYSA-N acetic acid;ethyl carbamate Chemical class CC(O)=O.CCOC(N)=O GJAYYEWRFJQMQK-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- XLJMAIOERFSOGZ-UHFFFAOYSA-N anhydrous cyanic acid Natural products OC#N XLJMAIOERFSOGZ-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 229940111759 benzophenone-2 Drugs 0.000 description 1
- ZNAAXKXXDQLJIX-UHFFFAOYSA-N bis(2-cyclohexyl-3-hydroxyphenyl)methanone Chemical compound C1CCCCC1C=1C(O)=CC=CC=1C(=O)C1=CC=CC(O)=C1C1CCCCC1 ZNAAXKXXDQLJIX-UHFFFAOYSA-N 0.000 description 1
- QSIUROSZHFBXDS-UHFFFAOYSA-N bis[2-(4-hydroxycyclohexyl)phenyl]methanone Chemical compound C1CC(O)CCC1C1=CC=CC=C1C(=O)C1=CC=CC=C1C1CCC(O)CC1 QSIUROSZHFBXDS-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- AJKZIPCWVAURSI-UHFFFAOYSA-N carbamic acid;2-methylprop-2-enoic acid Polymers NC(O)=O.CC(=C)C(O)=O AJKZIPCWVAURSI-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- QSAWQNUELGIYBC-UHFFFAOYSA-N cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCC1C(O)=O QSAWQNUELGIYBC-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical group C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- LTYMSROWYAPPGB-UHFFFAOYSA-N diphenyl sulfide Chemical compound C=1C=CC=CC=1SC1=CC=CC=C1 LTYMSROWYAPPGB-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- QCHWBGRKGNYJSM-UHFFFAOYSA-N ethene Chemical group C=C.C=C.C=C QCHWBGRKGNYJSM-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- IZKRUCWMNUNPEV-UHFFFAOYSA-N ethyl carbamate;3-oxobutanoic acid Chemical compound CCOC(N)=O.CC(=O)CC(O)=O IZKRUCWMNUNPEV-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000009863 impact test Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000004611 light stabiliser Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- MHSIVEMICAVDKL-UHFFFAOYSA-N methyl formate;toluene Chemical compound COC=O.CC1=CC=CC=C1 MHSIVEMICAVDKL-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- OTLDLKLSNZMTTA-UHFFFAOYSA-N octahydro-1h-4,7-methanoindene-1,5-diyldimethanol Chemical compound C1C2C3C(CO)CCC3C1C(CO)C2 OTLDLKLSNZMTTA-UHFFFAOYSA-N 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- FTDXCHCAMNRNNY-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1.OC1=CC=CC=C1 FTDXCHCAMNRNNY-UHFFFAOYSA-N 0.000 description 1
- UAGIUNHUUPYKPA-UHFFFAOYSA-N phenol;prop-2-enoic acid Chemical compound OC(=O)C=C.OC1=CC=CC=C1 UAGIUNHUUPYKPA-UHFFFAOYSA-N 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- CKFPWZPBRHQASN-UHFFFAOYSA-N phenyl-(4-propan-2-ylphenyl)methanone Chemical compound C1=CC(C(C)C)=CC=C1C(=O)C1=CC=CC=C1 CKFPWZPBRHQASN-UHFFFAOYSA-N 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical group NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- 239000011342 resin composition Substances 0.000 description 1
- 230000003678 scratch resistant effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- MDDUHVRJJAFRAU-YZNNVMRBSA-N tert-butyl-[(1r,3s,5z)-3-[tert-butyl(dimethyl)silyl]oxy-5-(2-diphenylphosphorylethylidene)-4-methylidenecyclohexyl]oxy-dimethylsilane Chemical compound C1[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)C(=C)\C1=C/CP(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 MDDUHVRJJAFRAU-YZNNVMRBSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Polymers C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- XKGLSKVNOSHTAD-UHFFFAOYSA-N valerophenone Chemical compound CCCCC(=O)C1=CC=CC=C1 XKGLSKVNOSHTAD-UHFFFAOYSA-N 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/46—Polymerisation initiated by wave energy or particle radiation
- C08F2/48—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
- C08F2/50—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
- C08F290/02—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
- C08F290/06—Polymers provided for in subclass C08G
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Polymerisation Methods In General (AREA)
- Polyurethanes Or Polyureas (AREA)
Abstract
Description
201211693 六、發明說明: 【發明所屬之技術領域】 本發明係_-種硬化性組合物,其係使用於透鏡 劑、稜鏡制、抗反射膜等用途,可形成高折射率且财擦 優異的被膜。 【先前技術】 在用以形成透鏡薄片之透鏡部分的塗膜劑等硬化性組合 物領域的情況下,為了提高自硬化性組合物所得硬化物之折: 率,故吾人研討芳香環之導入。例如周知有一種硬化型組合 物,其含有:具有芳香環之二(甲基)丙婦酸醋、及具有乙稀& 不飽和基的该二(甲基)丙烯酸酯以外之化合物(參照專利文獻 1)。但是,在該硬化型組合物之情形,雖然硬化物之折射率 高’不過藉由使剛性(rigid)成分導入於分子鏈中,而失去硬化 ,之柔軟性,結果是在硬錄產^加王時造成障礙;相對於 來自外部之應力引起可塑性變形(plastic def_ati〇n);耐 擦傷性降低的缺點。 方面’在目的為提高硬化物之耐擦傷性下,吾人當 彈性成分導入分子鏈中(參照專利文獻2及$。專利文獻2 載之鏡薄片係由活性能量線硬化性組合物之硬化物所形 ^,該活性能量線硬化性、组合物含有:聚己内醋改性胺基甲‘ ,(甲基)丙稀酸醋及具有(甲基)丙烯醯基之單體或寡聚物。但 疋,該硬化物雖然具有良好的耐擦傷性,不過折射率亦低。 人又,在專利文獻3記載一種薄片狀透鏡用樹脂組合物,1 t有i由高分子量之二醇化合物所得胺基甲酸酯(曱基)丙烯ΐ ^ 低:子里^—醇化合物所得胺基甲酸醋(甲基)丙埽酸 酯、具有苯基醚基的單丙烯酸酯及光聚合引發劑。但是,由該 物’並錢可藉由彈性成分之導人而設定心 率充分地高者,又耐擦傷性亦非充分之物。 【先前技術文獻】 201211693 【專利文獻1】日本特開2003-342329號公報 【專利文獻2】日本專利第414233〇號公報 【專利文獻3】日本專利第3979508號公報 【發明内容】 【發明欲解決之課題】 本發明係著眼於如前述先前技術之問題,其目的在 -種硬化性組合物,其可形成高折射率與優 可‘ 性良好地發揮之硬化物。 W生』吟衡 【解決課題之手段】 Μ 成ίίί的,縣發明之一態樣中,係提供一種硬 ί 喊其触物、硬錄化合物及硬化 鈉,同時该一笨酮或其衍生物之含量為13至4〇質量%。 錢 該二苯酮之y生物係例如下述化學式⑴所示之化合物。 II /—Λ R1 學式二示^基R2為氫、甲基、嶋、苯基或下述化201211693 VI. Description of the Invention: [Technical Field] The present invention is a curable composition which is used for a lens, a tantalum, an antireflection film, etc., and can form a high refractive index and is excellent in rubbing The film. [Prior Art] In the field of a curable composition such as a coating agent for forming a lens portion of a lens sheet, in order to increase the yield of the cured product obtained from the self-curable composition, the introduction of the aromatic ring has been studied. For example, there is known a hardening type composition comprising: a bis(meth) acetoacetate having an aromatic ring, and a compound other than the bis(meth) acrylate having an ethylene & unsaturated group (refer to the patent) Document 1). However, in the case of the hardening type composition, although the refractive index of the cured product is high, the hardening property is lost by the introduction of the rigid component into the molecular chain, and the result is hard recording. Wang Shi caused obstacles; plastic deformation (plastic def_ati〇n) due to stress from the outside; shortcomings of reduced scratch resistance. In view of the purpose of improving the scratch resistance of the cured product, the elastic component is introduced into the molecular chain (see Patent Documents 2 and $. The mirror sheet contained in Patent Document 2 is a cured product of the active energy ray-curable composition). The active energy ray hardenability, composition comprises: polycaprolactam modified amine methyl ', (meth) acryl vinegar and a monomer or oligomer having a (meth) acrylonitrile group. However, the cured product has a good scratch resistance, but has a low refractive index. Further, Patent Document 3 discloses a resin composition for a sheet lens, and 1 t has an amine derived from a high molecular weight diol compound. Carbamate (mercapto) propylene oxime ^ Low: Amino acid methacrylate (meth) acrylate, a phenyl ether group, a monoacrylate, and a photopolymerization initiator. In the case of the article, the heart rate is sufficiently high, and the scratch resistance is not sufficient. [Prior Art Document] 201211693 [Patent Document 1] Japanese Patent Laid-Open No. 2003-342329 Bulletin [Patent Document 2] Japanese Patent No. 41423 [Patent Document 3] Japanese Patent No. 3979508 [Description of the Invention] [Problems to be Solved by the Invention] The present invention has been made in view of the problems of the prior art described above, and the object thereof is to provide a curable composition which can be used. A high-refractive index and a good-acting hardened material are formed. W-sheng 吟 【 [the means to solve the problem] Μ into ίίί, one of the inventions of the county, provides a kind of hard 喊 shouting its touch, A hard-carrying compound and hardened sodium, and the content of the ketone or a derivative thereof is 13 to 4% by mass. The y-biosystem of the benzophenone is, for example, a compound represented by the following chemical formula (1). II / -Λ R1 Equation 2 shows that R2 is hydrogen, methyl, hydrazine, phenyl or the following
SS
CH (2) 該硬化性化合物較佳為活性能量線硬化性化合物、硬 較佳為光聚合引發劑。 該活性能量線硬化性化合物較佳為含有:含芳香環加 量%以上之胺基甲酸酯(甲基)丙烯酸酯或(甲基)丙烯酸氧 或者’該活性能量線硬化性化合物較佳為含有由有機異 酸酯與聚己内酯改性(甲基)丙烯酸烷酯之反應所形成之g 内酯改性胺基曱酸酯(甲基)丙烯酸酯。 人 【發明效果】 201211693 根據本發明可發揮下述效果。 本發明之硬化性組合物,含有二苯酮或其衍生物、硬化性 化合物及硬化劑,同時設定二苯酮或其衍生物之含量於13至 40質量%。藉由將1分子中具有二個苯環之二苯酮或其衍生物 之含夏>又疋於13質置%以上,而提高硬化性組合物中芳香環 之含量,結果可提高由硬化性組合物所形成之硬化物之折射 率。同時藉由將其含量設定在4〇質量%以下,而不會招致硬 化性組合物之硬化不良,可使硬化物之财擦傷性提高。 因此’根據本發明之硬化性組合物,可形成使高折射率與 優異耐擦傷性均衡性良好的發揮之硬化物。 【實施方式】 茲詳細說明使本發明具體化的實施形態如下。 本實施形態之硬化性組合物,係含有二苯酮或其衍生物、 硬化性化合物及硬化劑之物。而且,二苯酮或其衍生物之含量 5又疋於13至40質量%。藉由使1分子中具有二個苯環之二苯 酮或其衍生物含有預定量,而使由硬化性組合物所形成之硬化 物折射率高,又耐擦傷性亦優異。 茲就硬化性組合物中所含各成分依照順序說明如下。 <1.二苯酮或其衍生物> 二苯酮(C6H5COC6H5)係1分子中具有2個屬芳香環一種的 本環之化合物。该一本_,因本環之含量高,故具有使硬化性 組合物之硬化物之折射率提高的作用、與使耐擦傷性等物性提 高的作用。 二苯酮之衍生物方面,可使用下述化學式(1)所示之化合 物0 R1 R2 其中,R為氫,R為氳、曱基、羧甲基、苯基或下述化CH (2) The curable compound is preferably an active energy ray-curable compound, and is preferably a photopolymerization initiator. The active energy ray-curable compound preferably contains a urethane (meth) acrylate or (meth) acrylate having an aromatic ring added in an amount of at least %, or 'the active energy ray-curable compound is preferably A g-lactone-modified amino phthalate (meth) acrylate formed by a reaction of an organic isocyanate with a polycaprolactone-modified (meth)acrylic acid alkyl ester. [Effect of the Invention] 201211693 According to the present invention, the following effects can be exhibited. The curable composition of the present invention contains benzophenone or a derivative thereof, a curable compound and a curing agent, and the content of benzophenone or a derivative thereof is set to 13 to 40% by mass. By increasing the content of the aromatic ring in the curable composition by increasing the content of the aromatic ring in the curable composition by adding the summer content of the benzophenone or the derivative thereof having two benzene rings in one molecule to the above-mentioned 13% by mass. The refractive index of the cured product formed by the composition. At the same time, by setting the content to 4% by mass or less, the hardening property of the hardened composition is not caused, and the scratch resistance of the cured product can be improved. Therefore, according to the curable composition of the present invention, it is possible to form a cured product which exhibits a good balance between high refractive index and excellent scratch resistance. [Embodiment] An embodiment in which the present invention is embodied will be described in detail below. The curable composition of the present embodiment contains benzophenone or a derivative thereof, a curable compound, and a curing agent. Further, the content 5 of benzophenone or a derivative thereof is in the range of 13 to 40% by mass. When a benzophenone having two benzene rings in one molecule or a derivative thereof is contained in a predetermined amount, the cured product formed of the curable composition has a high refractive index and is excellent in scratch resistance. The components contained in the curable composition are described below in order. <1. Benzophenone or a derivative thereof> The benzophenone (C6H5COC6H5) is a compound having two rings of one aromatic ring in one molecule. In the present invention, since the content of the ring is high, the refractive index of the cured product of the curable composition is improved, and the physical properties such as scratch resistance are improved. As the derivative of benzophenone, a compound represented by the following chemical formula (1): R 1 R2 wherein R is hydrogen and R is fluorene, fluorenyl, carboxymethyl, phenyl or the like can be used.
5 201211693 學式(2)所示之官能基。5 201211693 The functional group shown by formula (2).
二苯酮衍生物之具體例方面,可例舉4_甲基-二苯酮、2,4,6_ 二甲基·一本嗣、鄰本▼酿基本甲酸甲醋、4-笨基二苯S同、4-苯 甲醯基-4’甲基二苯硫醚、4,4’-雙-4-二甲基胺基二苯酮、4,4,· 雙二乙基胺基二苯酮、2-羥基《4·甲氧基二苯酮、2-羥基·4· 正辛氧基二苯酮、2-羥基-4·氯二苯酮、2_羥基_5_氣二苯酮、2_ 說基-4-甲氧基-2 -叛基一本嗣、2,4-二經基二苯嗣、2 2’-二經 基甲氧基二苯酮等。 ’ 一工 在硬化性組合物中二苯酮或其衍生物之含量,為了有效地 顯現其功能’則設定於13至40質量%。在該含量低於13質 董%之情形,則難以提高該硬化物之折射率至所期望之等級, 同時耐擦傷性之提高亦變得困難。一方面,在含量超出4〇質 量°/〇之情形’則硬化性組合物之硬化性或成形性惡化。 <2.硬化性化合物> 在硬化性化合物方面,雖可使用以活性能量線硬化的化合 物或以加熱硬化的化合物’不過由使硬化速度加速並提高硬化 物之生產性之觀點’同時’由亦可提高硬化物之物性之觀點觀 之’較佳為活性能量線硬化性化合物❶在活性能量線硬化性化 合物方面,可適當使用具有芳香環30質量%以上的胺基甲酸 酯(甲基)丙烯酸酯、基)丙烯酸環氧酯、或其他單體。在該 情形’由活性能量線硬化性之觀點觀之,相較於甲基丙烯酸酯 以丙烯酸酯較佳。此外’本說明書中,丙烯酸酯與甲基丙烯酸 酉旨總稱為(甲基)丙嫦酸g旨。 在活性能量線硬化性化合物中所含有之前述芳香環之具 體例方面,可例舉苯基、伸苯基或萘基。在芳香環之含量低於 3〇質量%之情形’則難以使由硬化性組合物所得硬化物之折射 率充分地提高,同時’亦難以提高硬化物之表面硬度並提高耐 擦傷性。 201211693 知&又,作為活性能量線硬化性化合物,可適當使用由有機異 氰酸醋與聚己内醋改性(甲基)丙烯舰醋之反應所形成之聚 己内酯改性胺基甲酸酯(甲基)丙烯酸酯。 〔2.1胺基甲酸酯(甲基)丙烯酸酯〕 & t胺基甲酸酯(甲基)丙烯酸酯係由1分子中具有複數個異氰 酸醋基之有機異氰酸酯、及具有羥基之(甲基)丙烯酸酯之反應 所得。 在1分子中具有2個異氰酸酯基之有機異氰酸酯之具體例 ^面’可例舉二異氰酸甲伸苯酯、二異氰酸萘酯、二異氰酸二 苯基曱酯、二異氰酸異佛爾酮酯、二異氰酸苯二甲酯、二異氰 酸六亞甲酯、二異氰酸二環己基甲酯、二異氰酸2,2,4-三甲基 六亞甲酯、f基-2,6-二異氰酸酯己酸g旨、二異氰酸去曱伯酯等。 1分子中具有3個異氰酸酯基之有機異氰酸酯之具體例方 面’可例舉將二異氰酸酯經異三聚氰酸酯改性的下述化學式(3) 所示之化合物、使二異氰酸酯經加合改性的下述化學式(4)所 示之化合物、使二異氰酸酯經雙脲改性的下述化學式(5)所示 之化合物、2-異氰酸醋乙基-2,6-二異氰酸g旨己酸g旨三胺基壬烧 三異氰酸酯等。Specific examples of the benzophenone derivative may, for example, be 4-methyl-benzophenone, 2,4,6-dimethyl-one guanidine, ortho-based toluene methyl formate, 4-phenylidene diphenyl. S, 4-benzylidene-4'methyldiphenyl sulfide, 4,4'-bis-4-dimethylaminobenzophenone, 4,4, · bisdiethylaminodiphenyl Ketone, 2-hydroxy "4. methoxybenzophenone, 2-hydroxy·4·n-octyloxybenzophenone, 2-hydroxy-4·chlorobenzophenone, 2-hydroxyl-5-benzophenone 2, 基-4-methoxy-2-rebel-based oxime, 2,4-di-dibenzoquinone, 2 2'-di-dimethoxy benzophenone and the like. The content of benzophenone or a derivative thereof in the curable composition is set to 13 to 40% by mass in order to effectively exhibit its function. In the case where the content is less than 13% by mass, it is difficult to increase the refractive index of the cured product to a desired level, and the improvement in scratch resistance becomes difficult. On the other hand, in the case where the content exceeds 4 〇 mass / 〇, the hardenability or formability of the curable composition is deteriorated. <2. Curable compound> In the case of a curable compound, a compound which is hardened by an active energy ray or a compound which is hardened by heat can be used, but the viewpoint of accelerating the curing rate and improving the productivity of the cured product is simultaneously From the viewpoint of improving the physical properties of the cured product, it is preferable that the active energy ray-curable compound ❶ is an active energy ray-curable compound, and a urethane having an aromatic ring of 30% by mass or more can be suitably used. Acrylate, methacrylate epoxy ester, or other monomer. In this case, from the viewpoint of active energy ray hardenability, acrylate is preferable to methacrylate. Further, in the present specification, acrylate and methacrylic acid are collectively referred to as (meth)propionic acid g. The specific example of the aromatic ring contained in the active energy ray-curable compound may, for example, be a phenyl group, a phenylene group or a naphthyl group. When the content of the aromatic ring is less than 3% by mass, it is difficult to sufficiently increase the refractive index of the cured product obtained from the curable composition, and it is also difficult to increase the surface hardness of the cured product and improve the scratch resistance. 201211693 Known & Also, as the active energy ray-curable compound, a polycaprolactone-modified amine group formed by the reaction of organic isocyanic acid vinegar and polycaprolactone-modified (meth) propylene vinegar can be suitably used. Formate (meth) acrylate. [2.1 Amino acid ester (meth) acrylate] & t urethane (meth) acrylate is an organic isocyanate having a plurality of isocyanate groups in one molecule, and having a hydroxyl group ( The reaction of methyl) acrylate. Specific examples of the organic isocyanate having two isocyanate groups in one molecule may be exemplified by methyl phenyl diisocyanate, naphthyl diisocyanate, diphenyl decyl diisocyanate, diisocyanate. Isophorone ester, phenyl diisocyanate, hexamethylene diisocyanate, dicyclohexyl methyl diisocyanate, 2,2,4-trimethyl hexaisophthalic acid Methyl ester, f-based-2,6-diisocyanate hexanoic acid, deuterated diisocyanate, and the like. Specific examples of the organic isocyanate having three isocyanate groups in one molecule can be exemplified by a compound represented by the following chemical formula (3) in which a diisocyanate is modified with an isocyanurate, and the diisocyanate is modified. a compound represented by the following chemical formula (4), a compound represented by the following chemical formula (5) wherein a diisocyanate is modified with a diurea, 2-isocyanate ethyl-2,6-diisocyanate g is a hexanoic acid, a triamine-based triglyceride or the like.
NCO (3) NCO-R'NCO (3) NCO-R'
CC
R-NCO Ο ΟR-NCO Ο Ο
CH,OC-NH-R-NCO I ?CH, OC-NH-R-NCO I ?
CH3 — CHi— c 一 CHjO — C 一 NH - R—NCOCH3 — CHi— c — CHjO — C — NH — R—NCO
CH^OC-NH—R—NCO 化學式(3)及⑷中,R為 (4) 201211693CH^OC-NH—R—NCO In the chemical formulas (3) and (4), R is (4) 201211693
或or
^ -TO;— 0 或 0^-0 或 'W* An ^ CH3 CH3 0^ -TO;— 0 or 0^-0 or 'W* An ^ CH3 CH3 0
RR
CNH-^CH^—NCO NCO - (〇^)6 一 N (5)CNH-^CH^—NCO NCO - (〇^)6 a N (5)
XCNH~(CH2)6-NCO δ 具有經基之(甲基)丙稀酸醋之具體例方面,可例舉(甲美) 丙烯酸羥乙酯、(甲基)丙烯酸羥丙酯、(甲基)丙烯酸羥丁醋二 2-(甲基)丙烯醯氧乙基_2_羥乙酯、(甲基)丙烯酸2_羥基 苯氧基丙酯、鄰苯酚環氧丙醚(甲基)丙烯酸酯、三(基^二 酸新戊四醇醋等。 〔2·2 (曱基)丙烯酸環氧酯〕 丙稀酸環氧醋係由環氧樹脂與羧酸反應而得。 環氧樹脂之具體例方面,可例舉雙酚Α型環氧樹脂、 =ί 樹脂、雙齡s型環氧樹脂等之雙_環氧樹脂、萘 旨、聯苯基型環氧樹脂、萘盼骨架環氧樹脂、脂環式 二t月曰、齡式_清漆型環氧樹脂、甲盼式祕清漆型環氧 树月曰等之酚醛清漆型環氧樹脂等。 舰之具體例方面,可例舉丙婦酸、甲基丙稀酸、號轴酸 201211693 =基)丙烯醯氧乙醋、順丁婦二酸2_(甲基)丙缔 f 2·(甲基㈣醯氧乙醋、六氫酞酸2(甲基㈣酿氧乙曰醋 〔2.3其他單體〕 其他單體(稀釋單體)方面,可使用單官能之(T *曰、ϋϊ之(甲基)丙烯酸醋、多官能之(甲基)丙婦酸酿等席夂 丙稀酸醋之具體方面,可例舉駄酸單經乙A ^甲基)丙_醋、(甲基)丙烯酸2_乙氧基己醋、(甲基)丙湘^ 甲酸2-乙氧基乙醋、(f基)丙締酸2-乙氧 ί Γ甲基)丙稀酸2_經乙醋、(甲基)丙婦酸2-經5 =二I己内西曰改性(甲基)丙埽酸經乙醋、(f基)丙婦酸二 乙2吡咯啶酮、丙烯醯基嗎福啉、(甲基)丙烯ί ,、伯酉曰乙酉义乙烯醋、苯乙婦、(甲基)丙婦酸节醋 、(甲基)丙烯酸壬酚酯、(甲基)丙烯酸;氫 糠酉曰、(甲基)丙婦酸對枯稀酚酯等。 ㈣-ΐΐ基)丙稀酸醋之具體例方面,可例舉二(甲基)丙烯 1斤戊一醇酉日、一(甲基)丙烯酸1,9-壬二醇酯、二(甲基)丙嫌 酉^,6-己二醇酯、二(甲基)丙烯酸丨,4_丁二醇酯、二(甲基)丙烯 .酉夂二乙、二(甲基)丙婦酸三乙二醇醋、二(甲基)丙烯^ τί酯、二基)丙烯酸丙二醇酯、二(甲基)丙烯酸二丙 二醇S旨等。 ^吕能(甲基)丙烯酸酯之具體例方面,可例舉三(甲基)丙 稀k一^曱基丙酯、二(甲基)丙烯酸新戊四醇酯、三經甲基丙 烧之3 ^耳環烧加成物之三(甲基)丙婦酸醋、三經甲基丙 院之6莫耳環氧乙燒加成物之三(甲基)丙烯酸醋、三(甲基)丙 稀酸甘油丙氧§旨、六(曱基)丙烯酸二新戊四醇醋、二新戊四醇 之己=酯加成物之六(甲基)丙烯酸酯等。 刚述以外之其他單體,可使用雙酚A型二(甲基)丙烯酸 酯、雙酚F型二(甲基)丙烯酸酯、雙酚S型二(曱基)丙烯酸酯、 二(甲基)丙烯酸三環癸烷二甲醇酯、二(甲基)丙烯酸環己烷二 201211693 甲醇醋、9,9-雙[4-(2·(甲基)丙稀酿氧乙氧基)苯基]第等之寡聚 物。 〔2.4聚己内酯改性胺基甲酸酯(甲基)丙烯酸酯〕 聚己内酯改性胺基曱酸酯(T基)丙烯酸酯係藉由使有機 異氰酸酯與下述化學式(6)所示之聚己内酯改性烷基(甲基)丙 烯酸酯反應所得。有機異氰酸酯之具體例方面,可例舉與先前 例舉作為在1分子中具有2個或3個異氰酸8旨基之有機異氛酸 酯之具體例相同之物。XCNH~(CH2)6-NCO δ has a specific example of a trans (meth)acrylic acid vinegar, and may be exemplified by (meth) hydroxyethyl acrylate, hydroxypropyl (meth) acrylate, (methyl) ) hydroxybutyric acid bis 2-(methyl) propylene oxiranyl 2- hydroxyethyl ester, 2-hydroxyphenoxypropyl (meth) acrylate, o-phenol epoxidized ether (meth) acrylate , three (based diacid neopentyl alcohol vinegar, etc. [2·2 (fluorenyl) acrylate epoxy ester] acrylic acid epoxy vinegar is obtained by reacting epoxy resin with carboxylic acid. Examples include a bisphenol oxime type epoxy resin, a ί resin, a double age s type epoxy resin, and the like, an epoxy resin, a naphthalene type, a biphenyl type epoxy resin, and a naphthene skeleton epoxy resin. , phenol-type two-month 曰, age-type varnish-type epoxy resin, acetal-type varnish-type epoxy resin, such as phenolic varnish type epoxy resin, etc. Acid, methacrylic acid, succinic acid 201211693 = base) propylene oxime acetoacetate, cis-butanyl diacid 2_(methyl) propyl s-f 2 · (methyl (tetra) oxime acetoacetate, hexahydro phthalic acid 2 (Methyl (four) brewing oxyacetam vinegar [2.3 other monomers 〕 For other monomers (diluted monomers), monofunctional (T * 曰, ϋϊ (meth) acrylate vinegar, polyfunctional (methyl) propyl gluconate, etc. In the aspect, citric acid mono-ethyl A ^ methyl) propyl vinegar, (meth)acrylic acid 2 - ethoxy hexanoic acid, (methyl ) propyl hydrazine - 2-ethoxy ethoxy vinegar, (f Base) propionic acid 2-ethoxyoxinium methyl)propionic acid 2_ethyl acetoacetate, (methyl)propanoid 2 -5 = di-I-caprolactam modified (methyl)propionic acid By vinegar, (f-based) propyl acetophenone, 2-ethyl 2-pyrrolidone, acryl oxime porphyrin, (meth) propylene ε, 酉曰 酉曰 酉 乙烯 乙烯 乙烯 乙烯 苯 苯Glycolic acid vinegar, phenolic acid (meth) acrylate, (meth) acrylic acid; hydroquinone, (methyl) propyl benzoic acid, phenolic ester, etc. (4) - thiol) specific acrylic acid vinegar For example, bis(meth)propene 1 kg of pentaerythritol, 1 (9)-nonanediol (meth)acrylate, di(methyl)propene, 6-hexanediol Ester, bismuth (meth) acrylate, 4-butanediol ester, di(meth) propylene, bismuth diethylene, di(methyl) propylene glycolate triethylene glycol vinegar, di (a) ) ^ Τί propylene di-yl) acrylate, propylene glycol di (meth) acrylate, dipropylene glycol and the like S purpose. Specific examples of the Luneng (meth) acrylate may, for example, be tris(methyl) propyl ketopropyl ketone, dipentyl methacrylate, or trimethyl propyl acrylate. 3(E) earrings are added to the tris(methyl)-propyl vinegar vinegar, and the 3 m (meth) acrylate vinegar, tris(methyl) propyl acetate Dilute glycerol propoxy §, hexa(indenyl)acrylic acid, neopentyl glycol vinegar, dipentaerythritol, hexa-ester adduct, hexa(meth) acrylate, and the like. As the other monomers just mentioned, bisphenol A type di(meth)acrylate, bisphenol F type di(meth)acrylate, bisphenol S type di(indenyl)acrylate, di(methyl group) can be used. Tricyclodecane dimethanol acrylate, cyclohexane di(meth)acrylate 201211693 Methanol vinegar, 9,9-bis[4-(2·(methyl) propylene oxyethoxy)phenyl] The second oligomer. [2.4 Polycaprolactone-modified urethane (meth) acrylate] Polycaprolactone-modified amine phthalate (T-based) acrylate by using organic isocyanate with the following chemical formula (6) The polycaprolactone-modified alkyl (meth) acrylate is reacted as shown. Specific examples of the organic isocyanate are the same as those exemplified as the specific examples of the organic oleic acid ester having two or three isocyanic acid groups in one molecule.
R I. (6) CH2=CC〇-(CH2)„-〇- [C(CH2)30]m-H 〇 Ο 其中,R為氫或甲基、η為1至10之整數、m為i至25 之整數。 聚己内酯改性(甲基)丙稀酸烧酯之具體例方面,可例舉聚 己内酯改性(甲基)丙烯酸羥乙酯、聚己内酯改性(甲基)丙烯酸 羥丙酯、聚己内酯改性(甲基)丙烯酸羥丁酯等。 <3.硬化劑> 硬化劑係扮演使硬化性化合物硬化的角色。 硬化性化合物為活性能量線硬化性化合物之情形,係使用 光聚合引發劑。光聚合引發劑之具體例方面,可例舉例如異丙 基安息香醚、異丁基安息香醚、乙醯苯、2,4·二乙基9-^硫 、2-氣9-氧硫 、乙基.惠醌、對二甲基胺基苯τ酸異^ 酯、對二甲基胺基苯甲酸乙酯、1_羥基環己基苯酮、2_經^_2_ 甲基-1-苯基-丙烷-1-酮、2,2-二甲氧基-1,2·二苯基乙烷小^同、 2·苄基-2-二曱基胺基·1(4·嗎琳基(morpholino)苯基)-丁綱·ι、雙 (2,4,6-三甲基苯甲醯基)·苯基膦氧化物、甲酸甲基苄酯等。 在硬化性化合物具有經基之加熱硬化性化合物之情形,例 如有機異氰酸酯係使用作為硬化劑。在硬化性化合物具有環氧 基之加熱硬化性化合物之情形,則胺化合物、酸酐等係作為 201211693 化劑使用。 <硬化性組合物之硬化方法> 前述之硬化性組合物,可藉由紫外線或電子束等活性能量 線之照射,或藉由加熱使之硬化。例如,在塗布硬化性組合物 於透鏡表械基㈣絲錢,藉触脑⑽齡或加熱使 硬^生組合物硬化,而可形成被膜。在加熱所致硬化之情形, 通吊之加熱條件為70至9(TC且30分鐘至丨小時左右。 <硬化性組合物之用途> 由該硬化性組合物所得硬化物,可使用作為屬透鏡薄片一 種的稜鏡薄片或抗反射膜等。 (稜鏡薄片) 稜鏡薄片係在薄片狀基材上設置稜鏡部(透鏡部)。基材方 =,例如可使用聚對敗酸乙二酯(PET)、丙烯酸^樹脂、聚碳酸 ^曰等之合成樹脂製之物,較佳為透光性優異之物。在製造稜鏡 薄片之情形’則在預定之成形鑄模内注入活性能量線硬化性組 合,或加熱硬化性組合物,再者,在將基材配置於成形禱模之 預疋位置後,以活性能量線之照射或加熱使硬化性組合物硬 化。如此可獲得在基材上設置稜鏡部的稜鏡薄片。 在將活性能罝線硬化性組合物藉由紫外線之照射使之硬 化之情形,例如使用汞燈或金屬齒素燈,照射累計光量1〇〇至 5000mJ/cm2之紫外線為理想。一方面,在照射電子束予以硬 化之情形,較佳為以加速電壓150至250keV且1至20Mrad 之賴射量。 (抗反射膜) 抗反射膜係將由硬化性組合物所形成之層設置於基材薄 膜上,進一步在其上設置抗反射層❶在基材薄膜方面,雖可使 用合成樹脂製之薄臈或薄片、玻璃板等,不過其中以透明性之 觀點觀之’較佳為聚對醜酸乙二酯、丙烯酸樹脂、聚碳酸酯或 玻璃。抗反射層係由非結晶性之含氟聚合物般之折射率低的材 料所組成層。含氟聚合物之具體例方面,可例舉(甲基)丙埽酸 11 201211693 全氟烧醋、(甲基)丙埽酸三氟乙醋等予以共聚之物。 在製作抗反麵讀形,首先將活性能量線硬化性组合物 或加熱硬化性組合碰基材_,藉由能量線之照射 或加熱使硬化性組合物硬化後,在其上進一步塗裝非社晶性之 含氟聚合物等折射率低的材料使之硬化。在以 ,能量線硬化性,物硬化之情形,例如使用采燈^屬# 素燈,照射累什光置100至l〇〇〇mj/cm2之紫外線為理邦。一 方面,在照射電子束予以硬化之情形,較佳為加速電壓& 250keV且1至5Mmd之輻射量。 就以上實施形態所發揮的效果,茲歸納記載如下。 (1) 本實施形態之硬化性組合物含有二苯酮或其衍生物、 硬化性化合物及硬化劑,二苯酮或其衍生物之含量被設定於 ^3至40質量0/〇。藉由將1分子中具有二個苯環之二苯酮或其 衍士物之含量,:定於13質量%以上,而在硬化性組合物中芳 香環之含量變高,結果可提高硬化物之折射率。同時藉由設定 其含量於40質量%以下,而不會招致硬化性組合物之硬化不 良,可提高硬化物之耐擦傷性。 因此’根據本實施形態之硬化性組合物,可形成一種硬化 物,其可均衡性良好的發揮高折射率與優異耐擦傷性。 (2) 二苯酮衍生物方面,可使用前述化學式所示之化合 物。該化合物因芳香環之含量高,故目的在提高硬化物之折射 率’並提高耐擦傷性極為有用。 (3) 在硬化性組合物中所含硬化性化合物及硬化劑在各自 屬活性能量線硬化性化合物及光聚合引發劑之情形,則可使硬 化性組合物之硬化迅速化,並提高硬化物之生產性。 (4) 在硬化性組合物中所含之活性能量線硬化性化合物在 含有:含芳香環30質量%以上之胺基甲酸酯(甲基)丙烯酸酯或 (_,基)丙稀酸環氧酯之情形,硬化性組合物之芳香環含量提 高,結果可自硬化性組合物形成具有更高折射率及更優異耐擦 傷性之硬化物。 12 201211693 (5)硬化性組合物中所含有之活性能量線硬化性化合物在 含有藉由有機異氰酸酯與聚己内酯改性(甲基)丙烯酸烧醋之 反應所形成之聚己内酯改性胺基甲酸酯(甲基)丙稀酸酯之情 形,由於聚己内酯改;丨生胺基甲酸酯(甲基)丙烯酸酯之性質,不 僅提高硬化物表面損傷之復原性,同時亦可提高耐擦傷性。 【實施例】 兹例舉合成例、實施例及比較例,進一步具體說明該實施 形態如下。此外,在下述說明中,「份」為質量份、「%為質 量%之意。 ' (合成例 1 [HUA-4]) 混合丙烯酸2-羥基-3-苯氧基丙酯〔曰本化藥股份有限公 司製,Kayarad R-128H〕78.1份、二異氰酸4,4’_二苯基甲酯 〔MDI ’曰本聚胺基曱酸酯股份有限公司製,腿ii〇nate MT〕 41.9份及虱酿卓甲喊o.i份予以混合。使其於室溫保持分 鐘後,升溫至50°C為止,並在同溫度保持2小時,獲得胺基 甲酸酯丙烯酸酯(HUA-4)。 (合成例2 [UA-1]) 混合二異氰酸六亞甲酯之異三聚氰酸酯型〔BASF曰本股 份有限公司製,BasonatHI-100,異氰酸酯含量:22〇/0〕50份、 聚己内酯改性丙烯酸羥乙酯〔Daicel化學工業股份有限公司 製,Placcel FA2D[己内酯重複單位數2]〕90份及月桂酸二丁 錫鹽0.02份。使其在室溫保持30分鐘後,升溫至7(rc為止, 且在同溫度保持5小時’獲得胺基甲酸醋丙婦酸酯(ua_i)。 (合成例 3 [AcB-1]) 在具備攪拌機、溫度計、電容器及氮氣導入管的5〇〇ml 容積(part by volume)之燒瓶中,裝入甲苯100份,升溫至 為止。另外混合曱基丙烯酸甲酯30份、苯乙烯60份、曱基丙 婦酸2-羥乙酯10份、1,1’·偶氮雙小環己烧腈 (cyclohexanecarbonitrile)〔大塚化學股份有限公司製,ACHN〕 3份。將該單體混合物在該燒瓶中經2小時滴下,予以反應3 13 201211693 小時。其後,滴下甲苯5份、Ι,Γ-偶氮雙-1-環己烷腈(ACHN)O.l 份、偶氮雙-2-甲基丁腈〔曰本肼工業股份有限公司製,ABN-E〕 0.1份,使其反應1小時。進一步滴下甲苯5份、1,1’-偶氮雙 -1-環己烷腈(ACHN)O.l份、偶氮雙-2-甲基丁腈〔曰本肼工業 股份有限公司製,ABN-E〕0.1份,予以反應2小時,獲得丙 烯酸樹脂(AcB-1)。所得之丙烯酸樹脂AcB-Ι為固體成分 47.6%、羥價 20.6mgKOH/g。 (合成例 4 [HUA-1]) 混合丙烯酸2-羥基-3-苯氧基丙酯〔曰本化藥股份有限公 司製,KayaradR-128H〕88.2份、二異氰酸六亞甲酯〔HDI, 東京化成工業股份有限公司製〕31·8份及氫醌單甲醚0.1份。 使其在室溫下保持30分鐘後,升溫至50°C為止,並在同溫度 下保持4小時,獲得胺基甲酸酯丙烯酸酯(HUA-1)。 (合成例 5 [HUA-2]) 混合丙烯酸2_羥基-3-苯氧基丙酯〔曰本化藥股份有限公 司製,KayaradR-128H〕85.5份、二異氰酸苯二甲酯〔XDI, 東京化成工業股份有限公司製〕34.5份及氫醌單甲醚0.1份。 使其在室溫保持30分鐘後,升溫至50°C為止,並在同溫度下 保持2小時,獲得胺基甲酸酯丙烯酸酯(HUA-2)。 (合成例 6 [HUA-3]) 混合丙烯酸2-羥基-3-苯氧基丙酯〔日本化藥股份有限公 司製,Kayarad R-128H〕874份、二異氰酸甲伸苯酯〔TDI, 東京化成工業股份有限公司製〕32.7份及氫醌單甲醚0.1份。 使其在室溫下保持30分鐘後’升溫至5〇。(:為止,並在同溫度 下保持2小時,獲得胺基甲酸酯丙烯酸醋(HUA-3)。 (合成例 7 [HEA-1]) 在混合乙二醇二環氧丙醚〔共榮社化學股份有限公司製, Epolight40E〕100份、醜酸單羥乙基丙烯酸酯〔東亞合成股份 有限公司製,Aronics M-5400〕196.5份及氫醌單甲醚〇.〇4份、 三苯膦0_4份後,升溫至105°C為止,並在同溫度下保持4小 201211693 時,獲得丙烯酸環氧酯(HEA-l)。 (合成例 8 [HEA-2]) 在混合下述化學式(7)所示雙酚A型環氧樹脂(陶氏化學公 司(Dow Chemical Company)製 ’ DER331J ’ 重複單位數 n 約 0.1)100份、丙烯酸34.8份、氫醌單甲醚0.07份及三苯鱗〇 7 份後,升溫至l〇5°C,並在同溫度下保持4小時,獲得環氧丙 烯酸酯(HEA-2) 〇R I. (6) CH2=CC〇-(CH2)„-〇- [C(CH2)30]mH 〇Ο wherein R is hydrogen or methyl, η is an integer from 1 to 10, and m is from i to 25 The specific example of the polycaprolactone-modified (meth)acrylic acid ester is exemplified by polycaprolactone-modified (hydroxy) methacrylate and polycaprolactone (methyl) ) Hydroxypropyl acrylate, polycaprolactone modified (hydroxy) hydroxybutyl acrylate, etc. <3. Hardener> The hardener acts as a role in hardening the curable compound. The curable compound is active energy ray hardening. In the case of a compound, a photopolymerization initiator is used. Specific examples of the photopolymerization initiator include, for example, isopropyl benzoin ether, isobutyl benzoin ether, acetophenone, and 2,4·diethyl 9-. ^Sulfur, 2-gas 9-oxosulfuric acid, ethyl ketone, p-dimethylaminophenyl benzoate isophthalate, p-dimethylaminobenzoic acid ethyl ester, 1-hydroxycyclohexyl benzophenone, 2 _^^__methyl-1-phenyl-propan-1-one, 2,2-dimethoxy-1,2·diphenylethane small, 2·benzyl-2-didecyl Amino group 1 (4 morpholino phenyl)-Ding Gang·ι, bis(2,4,6-trimethylbenzylidene)·benzene Phosphine oxide, methyl benzyl formate, etc. In the case where the curable compound has a heat-curable compound having a base, for example, an organic isocyanate is used as a curing agent. In the case where the curable compound has an epoxy-based heat-curable compound, Further, an amine compound, an acid anhydride or the like is used as a chemical agent for 201211. <A method for curing a curable composition> The curable composition described above can be irradiated with an active energy ray such as ultraviolet rays or electron beams, or by heating For example, in the case where the curable composition is coated on the lens surface (four), the hardened composition is hardened by the brain (10) age or heating, and the film can be formed. The heating condition of the sling is 70 to 9 (TC and about 30 minutes to about hrs. <Use of the curable composition> The cured product obtained from the curable composition can be used as a enamel sheet of a type of lens sheet or Antireflection film, etc. (稜鏡 稜鏡 ) 稜鏡 稜鏡 稜鏡 稜鏡 稜鏡 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( It is preferable that the synthetic resin such as acrylic resin or polycarbonate is preferably excellent in light transmittance. In the case of producing a crucible sheet, an active energy ray hardening combination is injected into a predetermined molding mold, or Further, the curable composition is heated, and after the substrate is placed at the pre-twisting position of the shaping mode, the curable composition is cured by irradiation or heating with an active energy ray. In the case where the active energy entangled composition is hardened by irradiation with ultraviolet rays, for example, a mercury lamp or a metal guillo lamp is used, and an ultraviolet light having an integrated light amount of 1 〇〇 to 5000 mJ/cm 2 is ideal. . On the one hand, in the case where the electron beam is hardened, it is preferable to accelerate the voltage by 150 to 250 keV and 1 to 20 Mrad. (Anti-Reflection Film) The anti-reflection film is formed by providing a layer formed of a curable composition on a base film, and further providing an anti-reflection layer thereon. In the case of a base film, a synthetic resin can be used. A sheet, a glass plate or the like, but it is preferably a polyethylene terephthalate, an acrylic resin, a polycarbonate or a glass from the viewpoint of transparency. The antireflection layer is composed of a material having a low refractive index like a non-crystalline fluoropolymer. Specific examples of the fluoropolymer may be copolymerized with (meth)propionic acid 11 201211693 perfluoro vinegar or (methyl)propionic acid trifluoroacetic acid. In the preparation of the anti-back surface reading, first, the active energy ray-curable composition or the heat-curable composition is combined with the substrate _, and the curable composition is cured by irradiation or heating of the energy ray, and further coated thereon. A material having a low refractive index such as a crystalline fluoropolymer is hardened. In the case where the energy line is hardenable and the object is hardened, for example, using a lamp of the lamp, the ultraviolet light of the light is set to 100 to 1 mj/cm2. On the other hand, in the case where the electron beam is hardened by irradiation, it is preferable to accelerate the voltage & 250 keV and the amount of radiation of 1 to 5 Mmd. The effects exerted by the above embodiments are summarized as follows. (1) The curable composition of the present embodiment contains benzophenone or a derivative thereof, a curable compound, and a curing agent, and the content of benzophenone or a derivative thereof is set to be from 3-4 to 40 mass%. By setting the content of the benzophenone or the derivative thereof having two benzene rings in one molecule to 13% by mass or more, the content of the aromatic ring in the curable composition is increased, and as a result, the cured product can be improved. Refractive index. At the same time, by setting the content to 40% by mass or less without causing the hardening of the curable composition, the scratch resistance of the cured product can be improved. Therefore, according to the curable composition of the present embodiment, a cured product can be formed, which exhibits high refractive index and excellent scratch resistance with good balance. (2) As the benzophenone derivative, a compound represented by the above chemical formula can be used. Since this compound has a high content of an aromatic ring, it is extremely useful for improving the refractive index of a cured product and improving scratch resistance. (3) When the curable compound and the curing agent contained in the curable composition are each an active energy ray-curable compound and a photopolymerization initiator, the curing of the curable composition can be accelerated, and the cured product can be cured. Productive. (4) The active energy ray-curable compound contained in the curable composition contains a urethane (meth) acrylate or (-) acrylic acid ring containing 30% by mass or more of the aromatic ring. In the case of an oxyester, the aromatic ring content of the curable composition is increased, and as a result, a cured product having a higher refractive index and more excellent scratch resistance can be formed from the curable composition. 12 201211693 (5) The active energy ray-curable compound contained in the curable composition is modified with polycaprolactone formed by the reaction of organic isocyanate with polycaprolactone-modified (meth)acrylic acid vinegar In the case of urethane (meth) acrylate, due to the modification of polycaprolactone; the nature of the methacrylate (meth) acrylate not only improves the recovery of the surface damage of the cured product, but also It can also improve the scratch resistance. [Examples] The synthesis examples, the examples, and the comparative examples will be exemplified, and the embodiment will be further specifically described below. In addition, in the following description, "part" is a mass part, and "% is mass %." (Synthesis Example 1 [HUA-4]) Mixed 2-hydroxy-3-phenoxypropyl acrylate [曰本化Pharmaceutical Co., Ltd., Kayarad R-128H] 78.1 parts, 4,4'-diphenylmethyl diisocyanate [MDI '曰本polyamine phthalate Co., Ltd., leg ii〇nate MT] 41.9 parts and brewed 甲 喊 oi were mixed, kept at room temperature for a minute, heated to 50 ° C, and kept at the same temperature for 2 hours to obtain urethane acrylate (HUA-4) (Synthesis Example 2 [UA-1]) Heteropolycyanate type of hexamethylene diisocyanate (Basilat HI-100, isocyanate content: 22 〇 / 0) 50 And polycaprolactone-modified hydroxyethyl acrylate [manufactured by Daicel Chemical Industry Co., Ltd., Placcel FA2D [caprolactone repeat unit number 2]] 90 parts and butyl laurate 0.02 parts. After maintaining for 30 minutes, the temperature was raised to 7 (rc and kept at the same temperature for 5 hours) to obtain urethane acetoacetate (ua_i). (Synthesis Example 3 [AcB-1]) A 5 〇〇 ml part by volume flask of a stirrer, a thermometer, a capacitor, and a nitrogen gas introduction tube was charged with 100 parts of toluene, and the temperature was raised until 30 parts of methyl methacrylate, 60 parts of styrene, and hydrazine were mixed. 10 parts of 2-hydroxyethyl propyl acrylate, 1, 1, ' azocyclocarbonitrile (manufactured by Otsuka Chemical Co., Ltd., ACHN) 3 parts. The monomer mixture was placed in the flask. After 2 hours of dropping, the reaction was carried out for 3 13 201211693 hours. Thereafter, 5 parts of toluene, hydrazine, hydrazine-azobis-1-cyclohexanecarbonitrile (ACHN), oxygen, azobis-2-methylbutyronitrile were added. 0.1 parts of ABN-E, manufactured by Sakamoto Co., Ltd., and allowed to react for 1 hour. Further, 5 parts of toluene and 1,1'-azobis-1-cyclohexanecarbonitrile (ACHN) of Ol, 0.1 parts of azobis-2-methylbutyronitrile (ABN-E, manufactured by Sakamoto Co., Ltd.) was reacted for 2 hours to obtain an acrylic resin (AcB-1). The obtained acrylic resin AcB-Ι was solid. The composition was 47.6%, and the hydroxyl value was 20.6 mgKOH/g. (Synthesis Example 4 [HUA-1]) Mixed 2-hydroxy-3-phenoxypropyl acrylate [曰本化制药股份有限公司System, Kayarad R-128H] 88.2 parts, hexamethylene diisocyanate [HDI, manufactured by Tokyo Chemical Industry Co., Ltd.) 31·8 parts and hydroquinone monomethyl ether 0.1 parts. Keep it at room temperature for 30 parts. After a minute, the temperature was raised to 50 ° C and maintained at the same temperature for 4 hours to obtain urethane acrylate (HUA-1). (Synthesis Example 5 [HUA-2]) Mixed acrylic acid 2-hydroxy-3-phenoxypropyl ester (Kayarad R-128H, manufactured by Sakamoto Chemical Co., Ltd.) 85.5 parts, phenyl diisocyanate [XDI] 34.5 parts of Tokyo Chemical Industry Co., Ltd. and 0.1 parts of hydroquinone monomethyl ether. After maintaining at room temperature for 30 minutes, the temperature was raised to 50 ° C and maintained at the same temperature for 2 hours to obtain urethane acrylate (HUA-2). (Synthesis Example 6 [HUA-3]) Mixed acetyl 2-hydroxy-3-phenoxypropyl acrylate (Kayarad R-128H, manufactured by Nippon Kayaku Co., Ltd.), 874 parts, and phenylphenyl diisocyanate [TDI] 32.7 parts of Tokyo Chemical Industry Co., Ltd. and 0.1 parts of hydroquinone monomethyl ether. After allowing to stand at room temperature for 30 minutes, the temperature was raised to 5 Torr. (:, and kept at the same temperature for 2 hours to obtain urethane acrylate vinegar (HUA-3). (Synthesis Example 7 [HEA-1]) In the mixed ethylene glycol diglycidyl ether Co., Ltd., Epolight 40E] 100 parts, ugly acid monohydroxyethyl acrylate (manufactured by Toagosei Co., Ltd., Aronics M-5400) 196.5 parts and hydroquinone monomethyl ether 〇. 4 parts, triphenylphosphine After 0_4 parts, the temperature was raised to 105 ° C, and when the temperature was kept at 4 hours 201211693, the epoxy acrylate (HEA-1) was obtained. (Synthesis Example 8 [HEA-2]) The following chemical formula (7) was mixed. Bisphenol A type epoxy resin (Dard Chemical Company's 'DER331J' repeating unit number n about 0.1) 100 parts, acrylic acid 34.8 parts, hydroquinone monomethyl ether 0.07 parts and triphenyl scales After 7 parts, the temperature was raised to l〇5 ° C and maintained at the same temperature for 4 hours to obtain epoxy acrylate (HEA-2) 〇
(合成例 9 [HEA-3]) 在混合秦型壞氧樹脂〔DIC股份有限公司製,epiclON HP4032〕150份、丙稀酸46份、氫醌單甲謎〇.〇7份及三苯膦 0.7份後,升溫至l〇5°C為止,並在同溫度下保持4小時,獲 得丙烯酸環氧酯(HEA-3)。 " (合成例 10 [ΗΕΑ-4]) 在混合下述化學式(8)所示酚伸聯苯型環氧樹脂〔日本化 藥股份有限公司製,NC-3000〕100份、丙烯酸24.8份、氫醌 單甲醚0.02份及三苯膦〇.2份後,升溫至1〇5它為止,並在同 溫度下保持4小時,獲得丙烯酸環氧酯(HgA_4)。(Synthesis Example 9 [HEA-3]) 150 parts of mixed type Qin Oxygen Resin [made by DIC Co., Ltd., epiclON HP4032], 46 parts of acrylic acid, hydroquinone, and 7 parts of triphenylphosphine. After 0.7 parts, the temperature was raised to 10 ° C and maintained at the same temperature for 4 hours to obtain an epoxy acrylate (HEA-3). < (Synthesis Example 10 [ΗΕΑ-4]) 100 parts of a phenol-extended biphenyl type epoxy resin (NC-3000, manufactured by Nippon Kayaku Co., Ltd.) and 24.8 parts of acrylic acid, which are represented by the following chemical formula (8), After 0.02 parts of hydroquinone monomethyl ether and 2 parts of triphenylphosphine, the temperature was raised to 1 〇 5 and maintained at the same temperature for 4 hours to obtain an epoxy acrylate (HgA_4).
(合成例 11 [HEA-5]) 混合雙酚A型環氧樹脂(陶氏化學公司製,DER331J,重 複單位數η約0.1)100份、f基丙埽酸9份、氫酿單甲轉〇 15 201211693 份及三苯膦0.7份後,升溫至105°C為止,並在同溫度下保持 4小時,獲得曱基丙烯酸環氧酯(HEA-5)。 (合成例 12 [UA-2]) 混合二異氰酸六亞甲酯之異三聚氰酸酯型〔BASF日本股 份有限公司製,Basonat HI-100,異氰酸酯含量:22%〕50份、 聚己内酯改性丙婦酸經乙酯〔Daicel化學工業股份有限公司 製,Placed FA5,己内酯重複單位數5〕180份及月桂酸二丁 錫鹽0.02份。使其在室溫下保持30分鐘後,升溫至70°C為止, 並在同溫度下保持5小時’獲得胺基曱酸醋丙稀酸醋(UA-2) ◊ (合成例 13 [UA-3]) 混合二異氰酸六亞甲酯之異三聚氰酸酯型〔BASF日本股 份有限公司製’ Basonat HI-100,異氰酸酯含量22%〕50份、 聚己内酯改性丙烯酸羥乙酯〔Daicel化學工業股份有限公司 製,PlaccelFAl,己内酯重複單位數1〕60.4份及月桂酸二丁 錫鹽0_02份。使其在室溫下保持30分鐘後,升溫至7(TC為止, 並在同溫度下保持5小時,獲得胺基甲酸酯丙烯酸酯(ua-3)。 (合成例 14 [UA-4]) 混合一異氣酸4,4’-二苯基甲醋〔日本聚胺基甲酸g旨股份 有限公司製’ MillionateMT ’異氰酸酯含量:33.5%〕50份、 聚己内酯改性丙稀酸羥乙酯〔Daicel化學工業股份有限公司 製,Placed FA2D ’己内酯重複單位數2〕144.5份及月桂酸二 丁錫鹽0.02份。使其在室溫下保持30分鐘後,升溫至7(rc為 止,並在同溫度下保持5小時,獲得胺基甲酸酯丙烯酸酯 (UA-4)» (合成例 15 [UA-5]) 混合二異氣酸4,4’-二苯基甲g旨〔日本聚胺基甲酸g旨股份 有限公司製,MillionateMT,異氰酸酯含量:33.5%〕50份、 聚己内酯改性丙稀酸羥乙酯〔Daicel化學工業股份有限公司 製,Placcel FA1,己内酯重複單位數1〕96.6份及月桂酸二丁 錫鹽0.02份。使其在室溫下保持30分鐘後,升溫至7〇。(:為止, 201211693 並在同溫度下保f 5^、時,獲得 〈硬化性化合物”香環含 _㈣UA·5) ,,,i至15所得之各硬化性化合物中依照下式 4舁%香環含量。結果如表1至表4所示。(Synthesis Example 11 [HEA-5]) 100 parts of mixed bisphenol A type epoxy resin (manufactured by The Dow Chemical Co., Ltd., DER331J, repeating unit number η: about 0.1), 9 parts of f-propionic acid, and hydrogen-branched single-turn 〇15 201211693 parts and 0.7 parts of triphenylphosphine, the temperature was raised to 105 ° C, and kept at the same temperature for 4 hours to obtain methacrylic acid epoxy ester (HEA-5). (Synthesis Example 12 [UA-2]) Mixed isomeric isocyanate type of hexamethylene diisocyanate [Basson Japan HI-100, isocyanate content: 22%] 50 parts, poly Caprolactone-modified propylene glycol acid was subjected to 180 parts of ethyl ester [Daicel Chemical Industry Co., Ltd., Placed FA5, caprolactone repeating unit number 5] and 0.02 parts of dibutyltin laurate. After maintaining at room temperature for 30 minutes, the temperature was raised to 70 ° C, and kept at the same temperature for 5 hours to obtain an amino phthalic acid acetoacetate (UA-2) ◊ (Synthesis Example 13 [UA- 3]) Iso-polycyanate type of mixed hexamethylene diisocyanate [Basson HI-100, manufactured by BASF Japan Co., Ltd., isocyanate content 22%] 50 parts, polycaprolactone modified hydroxy acrylate Ester (made by Daicel Chemical Industry Co., Ltd., Placcel FAl, caprolactone repeating unit number 1) 60.4 parts and dibutyltin laurate 0_02 parts. After maintaining at room temperature for 30 minutes, the temperature was raised to 7 (TC) and kept at the same temperature for 5 hours to obtain urethane acrylate (ua-3). (Synthesis Example 14 [UA-4] Mixing 4,4'-diphenylmethyl acetonate [Michineate MT 'isocyanate content: 33.5%] 50 parts, polycaprolactone modified acrylic acid hydroxy Ethyl ester (made by Daicel Chemical Industry Co., Ltd., Placed FA2D 'caprolactone repeating unit number 2) 144.5 parts and butyl butyl laurate 0.02 parts. After being kept at room temperature for 30 minutes, the temperature was raised to 7 (rc). So far, and kept at the same temperature for 5 hours, to obtain urethane acrylate (UA-4)» (Synthesis Example 15 [UA-5]) Mixed diisoxamic acid 4,4'-diphenylmethylg 50 [Millionate MT, isocyanate content: 33.5%] 50 parts, polycaprolactone modified hydroxyethyl acrylate (Daicel Chemical Industry Co., Ltd., Placcel FA1, The number of lactone repeating units was 1] 96.6 parts and 0.02 parts of dibutyltin laurate. After being kept at room temperature for 30 minutes, the temperature was raised to 7 〇. (: So far, 201211693 and at the same temperature to maintain f 5 ^, when the <curable compound" scented ring contains _ (four) UA · 5),, i to 15 obtained in each of the curable compounds according to the following formula 4 % aroma ring content. The results are shown in Tables 1 to 4.
在硬化性化合物中芳香環含量(質量%)=〔(芳香環分子量χ 芳香環數)/硬化性化合物之分子量〕xlOO 例如在合成例1所得胺基甲酸酯丙烯酸酯HUA-4中芳香 環含量,係以此方法依照下述計算。 R-128H係分子量222,芳香環(苯基)之數有1個^ mdi 係分子量250、芳香環(伸苯基)之數有2個。苯基之分子量為 77、伸苯基之分子量為76。而且’ R-128H與MDI之反應莫 耳比率為R-128H : MDI==2.1 : 1。因此’胺基甲酸酯丙烯酸酯 HUA-4 中芳香環含量為〔(77χ2.1+76χ2)/(222χ2.1+250)〕 χ 100=43.8(%)。 【表1】 HUA-1 HUA-2 HUA-3 HUA-4 HDI 〇 - - XDI • 〇 - TDI - 〇 - MDI - - 〇 R-128H 〇 〇 〇 〇 芳香環含量 (質量%) 25.5 36.3 37.1 43.8 【表2】 HEA-1 HEA-2 HEA-3 HEA-4 HEA-5 乙二醇 二環氧丙醚 〇 - - - 雙酚A型 環氧樹脂 - 0 - - 〇 萘型 環氧樹脂 - - 〇 - - 酚伸聯苯型 環氧樹脂 - - 〇 -In the curable compound, the content of the aromatic ring (% by mass) = [(the molecular weight of the aromatic ring χ the number of aromatic rings) / the molecular weight of the curable compound] xlOO, for example, the aromatic ring in the urethane acrylate HUA-4 obtained in Synthesis Example 1. The content is calculated in this way according to the following. R-128H has a molecular weight of 222, and the number of aromatic rings (phenyl) has two mdi-based molecular weights of 250 and two aromatic rings (phenylene). The molecular weight of the phenyl group is 77, and the molecular weight of the extended phenyl group is 76. Further, the reaction molar ratio of 'R-128H to MDI is R-128H: MDI==2.1:1. Therefore, the content of the aromatic ring in the 'urethane acrylate HUA-4 is [(77 χ 2.1 + 76 χ 2) / (222 χ 2.1 + 250)] χ 100 = 43.8 (%). [Table 1] HUA-1 HUA-2 HUA-3 HUA-4 HDI 〇- - XDI • 〇- TDI - 〇- MDI - - 〇R-128H 〇〇〇〇 aromatic ring content (% by mass) 25.5 36.3 37.1 43.8 [Table 2] HEA-1 HEA-2 HEA-3 HEA-4 HEA-5 Ethylene glycol diglycidyl ether - - - Bisphenol A type epoxy resin - 0 - - 〇naphthalene type epoxy resin - - 〇- - Phenol extended biphenyl type epoxy resin - - 〇 -
17 201211693 丙烯酸 〇 〇 〇 - 甲基丙烯酸 - - - 〇 酞酸單羥 乙基丙烯酸酯 〇 - - - - 芳香環含量 (質量%) 22.2 32.4 34.4 52.0 30.7 【表3】 PEG-DA3 ACMO PPEG-A1 BZ-A OPP-A 芳香環含量 (質量%) 0 0 40.1 47.5 57.1 【表4】 UA-1 UA-2 UA-3 UA-4 UA-5 HDI Nurate 〇 〇 〇 - MDI • - - 〇 〇 FA1 - 〇 - 〇 FA2 〇 • - 〇 - FA5 _ 〇 - - - 芳香環含量 (質量%) 0 0 0 15.6 20.7 (實施例1) 混合二苯自同〔BASF日本股份有限公司製,DAROCURE BP〕15份、三羥甲基丙烷EO改性三丙烯酸酯〔東亞合成股 份有限公司製,Aronics M-360,環氧乙烧合計加成6莫耳〕85 份及1-羥基-環己基-苯基-酮〔BASF日本股份有限公司製, Irgacure 184D〕4份,獲得活性能量線硬化性組合物。在所得 之活性能量線硬化性組合物中照射累計光量400mJ/cm2之紫 外線予以硬化,將由其硬化物所組成稜鏡部分形成於PET薄 膜上來製作稜鏡薄片。 (實施例2) 混合二苯酮〔BASF日本股份有限公司製,DAROCURE Bp〕25份、以合成例6所得之胺基甲酸酯丙烯酸酯(HUA-3)75 份及1-經基-環己基-苯基-酮〔BASF日本股份有限公司製, 18 20121169317 201211693 Barium Acrylate - Methacrylic Acid - - - Monohydroxyethyl acrylate 〇 - - - - Aromatic ring content (% by mass) 22.2 32.4 34.4 52.0 30.7 [Table 3] PEG-DA3 ACMO PPEG-A1 BZ-A OPP-A Aromatic ring content (% by mass) 0 0 40.1 47.5 57.1 [Table 4] UA-1 UA-2 UA-3 UA-4 UA-5 HDI Nurate 〇〇〇- MDI • - - 〇〇FA1 - 〇- 〇FA2 〇• - 〇-FA5 _ 〇- - - Aromatic ring content (% by mass) 0 0 0 15.6 20.7 (Example 1) Mixed diphenyl self-contained (BASF Japan Co., Ltd., DAROCURE BP) 15 , Trimethylolpropane EO modified triacrylate [manufactured by Toagosei Co., Ltd., Aronics M-360, Ethylene Ethylene Ethylene Addition 6 Mohr] 85 parts and 1-hydroxy-cyclohexyl-phenyl- 4 parts of a ketone (manufactured by BASF Japan Co., Ltd., Irgacure 184D) was used to obtain an active energy ray-curable composition. An ultraviolet ray having a cumulative light amount of 400 mJ/cm 2 was applied to the obtained active energy ray-curable composition to be cured, and a ruthenium portion composed of the cured product was formed on the PET film to prepare a ruthenium sheet. (Example 2) 25 parts of benzophenone (DAROCURE Bp, manufactured by BASF Japan Co., Ltd.), 75 parts of urethane acrylate (HUA-3) obtained in Synthesis Example 6, and 1-amino-ring Hexyl-phenyl-ketone [BASF Japan Co., Ltd., 18 201211693
Irgacure 184D〕4份,獲得活性能量線硬化性組合物。而且, 與實施例1同樣地,將由活性能量線硬化性組合物之硬化物所 組成棱鏡部分形成於PET薄膜上來製作棱鏡薄片。 (實施例3) 混合二苯酮〔BASF日本股份有限公司製,DAROCURE BP〕40份、雙酚A型手Ο改性二丙烯酸酯〔日本化藥股份有 限公司製’Kayarad R-55卜環氧乙烷合計加成4莫耳〕60份 及1-羥基-環己基-苯基-酮〔BASF日本股份有限公司製, Irgacure 184D〕4份,獲得活性能量線硬化性組合物。而且, 與實施例1同樣地,將由活性能量線硬化性組合物之硬化物所 組成稜鏡部分形成於PET薄膜上,來製作稜鏡薄片。 (實施例4) 混合4-苯甲醯基-4’-甲基二苯硫鱗((4-benzoyl-4 ’-methyl diphenyl sulphide),双邦實業股份有限公司(SHUANG-BANG INDUSTRIAL CORP)製 ’ SB-PI 705)25 份、以合成例 3 所得之 丙烯酸樹脂(AcB-l)158份及二異氰酸六亞甲醋〔東京化成工業 股份有限公司製〕4.9份’獲得加熱硬化性組合物。而且,在 成形鑄模内注入溶劑乾燥後之加熱硬化性組合物,以8〇。〇、 30分鐘之條件硬化,將由該加熱硬化性組合物之硬化物所組 成棱鏡部分形成於PET薄膜上,來製作稜鏡薄片。 又,使用該加熱硬化性組合物,來製作抗反射膜。亦即, 將該加熱硬化性組合物塗裝於作為基材薄膜之PET薄膜,在 80°C、30分之條件下予以硬化,形成了由其硬化物所組成層(厚 度100μιη)。接著,將混合Opstar JM5010〔JSR股份有線公司 製〕,100份與1-經基-環己基-苯基_酮〔BASF日本股份有限公 司製,Irgacure i84D〕〇.3份而成之塗膜劑塗裝於由該硬化物 戶^組成層之上,照射累計光量4〇〇mj/cm2之紫外線予以硬化, 形成低折射率層(厚度〇·1μιη),而作成抗反射膜。 (實施例5) ' 混合4-甲基二苯酮〔大同化成工業股份有限公司製, 201211693 DAIDO UV-CURE PMB〕25份、以合成例6所得之胺基甲酸 酯丙烯酸酯(HUA-3)75份及1-羥基-環己基-苯基酮〔BASF曰 本股份有限公司製,Irgacure 184D〕4份,獲得活性能量線硬 化性組合物。而且,與實施例1同樣地,將由活性能量線硬化 性組合物之硬化物所組成棱鏡部分形成於PET薄膜上,來製 作稜鏡薄片。 (實施例6) 混合鄰苯曱醯基苯甲酸甲酯(双邦實業股份有限公司製, SB-PI 711)25份、以合成例6所得之胺基曱酸酯丙烯酸酯 (HUA-3)75份及1-羥基-環己基-苯基-酮〔BASF日本股份有限 公司製,Irgacure 184D〕4份,獲得活性能量線硬化性組合物。 而且,與實施例1同樣地將由活性能量線硬化性組合物之硬化 物所組成棱鏡部分形成於PET薄膜上,來製作稜鏡薄片。 (實施例7) 混合4·苯甲醯基-4’-曱基二苯硫醚(双邦實業股份有限公 司製,SB-PI 705)25份、以合成例6所得之胺基甲酸酯丙烯酸 酯(HUA-3)75份及1-羥基-環己基-苯基-酮〔BASF日本股份有 限公司製,Irgacure 1·84ϋ〕4份,獲得活性能量線硬化性組合 物。而且,與實施例1同樣地,將由活性能量線硬化性組合物 之硬化物所組成稜鏡部分形成於PET薄膜上,來製作棱鏡薄 片。 (實施例8) 混合二苯酮〔BASF曰本股份有限公司製,DAROCURE BP〕25份、以合成例9所得之丙烯酸環氧酯(HEA-3)75份及 1-髮基-¾己基-本基-酮〔BASF日本股份有限公司製,irgacure 184D〕4份,獲得活性能量線硬化性組合物。接著,與實施例 1同樣地,將由活性能量線硬化性組合物之硬化物所組成稜鏡 部分形成於PET薄膜上,來製作棱鏡薄片。 (實施例9)4 parts of Irgacure 184D], an active energy ray-curable composition was obtained. Further, in the same manner as in Example 1, a prism portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a prism sheet. (Example 3) 40 parts of benzophenone (DAROCURE BP, manufactured by BASF Japan Co., Ltd.), bisphenol A type hand-modified diacrylate (Kayarad R-55 epoxy manufactured by Nippon Kayaku Co., Ltd.) 60 parts of ethane and 4 parts of 1-hydroxy-cyclohexyl-phenyl-ketone (manufactured by BASF Japan Co., Ltd., Irgacure 184D) were added in an amount of 4 parts to obtain an active energy ray-curable composition. Further, in the same manner as in Example 1, a crucible portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a crucible sheet. (Example 4) 4-(4-benzoyl-4'-methyl diphenyl sulphide) was mixed, manufactured by SHUANG-BANG INDUSTRIAL CORP. 'SB-PI 705) 25 parts, 158 parts of acrylic resin (AcB-1) obtained in Synthesis Example 3, and 4.9 parts of ii hexamethylene diacetate (manufactured by Tokyo Chemical Industry Co., Ltd.) to obtain a heat-curable combination Things. Further, a heat-curable composition obtained by drying a solvent in a molding mold was placed at 8 Torr. The crucible was cured under conditions of 30 minutes, and a prism portion composed of a cured product of the heat-curable composition was formed on a PET film to prepare a crucible sheet. Moreover, the heat-resistant composition was used to produce an antireflection film. In other words, the heat-curable composition was applied to a PET film as a base film, and cured at 80 ° C for 30 minutes to form a layer (thickness: 100 μm) composed of the cured product. Next, a coating agent prepared by mixing Opstar JM5010 [manufactured by JSR Co., Ltd.], 100 parts, and 1-carbo-cyclohexyl-phenyl ketone [Irgacure i84D, manufactured by BASF Japan Co., Ltd.] was added. It is coated on the layer composed of the cured product, and is irradiated with ultraviolet rays having an accumulated light amount of 4 〇〇mj/cm 2 to form a low refractive index layer (thickness 〇·1 μm) to form an antireflection film. (Example 5) '25 parts of mixed 4-methylbenzophenone (manufactured by Datong Chemical Industry Co., Ltd., 201211693 DAIDO UV-CURE PMB), and urethane acrylate obtained in Synthesis Example 6 (HUA-3) 75 parts and 1 part of 1-hydroxy-cyclohexyl-phenyl ketone (manufactured by BASF Co., Ltd., Irgacure 184D) were used to obtain an active energy ray-curable composition. Further, in the same manner as in Example 1, a prism portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to produce a ruthenium sheet. (Example 6) 25 parts of methyl ortho-benzoylbenzoate (SB-PI 711, manufactured by Shuangbang Industrial Co., Ltd.), and the amino phthalate acrylate (HUA-3) obtained in Synthesis Example 6 were mixed. In an amount of 4 parts, 75 parts of 1-hydroxy-cyclohexyl-phenyl-ketone (manufactured by BASF Japan Co., Ltd., Irgacure 184D) was used to obtain an active energy ray-curable composition. Further, in the same manner as in Example 1, a prism portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a ruthenium sheet. (Example 7) 25 parts of 4, benzylidene-4'-mercaptodiphenyl sulfide (SB-PI 705, manufactured by Shuangbang Industrial Co., Ltd.) was mixed, and the urethane obtained in Synthesis Example 6 was mixed. 75 parts of acrylate (HUA-3) and 4 parts of 1-hydroxy-cyclohexyl-phenyl-ketone (manufactured by BASF Japan Co., Ltd., Irgacure 1.84 Å) were used to obtain an active energy ray-curable composition. Further, in the same manner as in Example 1, a ruthenium portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a prism sheet. (Example 8) 25 parts of benzophenone (manufactured by BASF Co., Ltd., DAROCURE BP), 75 parts of epoxy acrylate (HEA-3) obtained in Synthesis Example 9, and 1-fatho--3⁄4 hexyl group- 4 parts of a ketone-ketone [manufactured by BASF Japan Co., Ltd., irgacure 184D], an active energy ray-curable composition was obtained. Then, in the same manner as in Example 1, a ruthenium portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a prism sheet. (Example 9)
混合二苯酮〔BASF日本股份有限公司製,DAROCURE 201211693 BP〕15份、六丙烯酸二新戊四醇酯〔新中村化學工業股份有 限公司製,NK酯A-DPH〕25份、丙烯醯基嗎福啉〔興人股 份有限公司製’ ACMO〕60份及1-羥基-環己基-苯基-網〔BASF 曰本股份有限公司製,Irgacure 184D〕4份,獲得活性能量線 硬化性組合物。而且’與實施例1同樣地,將由活性能量線硬 化性組合物之硬化物所組成稜鏡部分形成於PET薄膜上,來 製作棱鏡薄片。 (實施例10) 混合二苯酮〔BASF日本股份有限公司製,DAROCURE BP〕25份、以合成例7所得之丙烯酸環氧酯(HEA-1)25份、 丙烯醯基嗎福啉〔興人股份有限公司製,ACMO〕50份及1-經基-¾己基-本基-嗣〔BASF日本股份有限公司製,irgacure 184D〕4份’獲得活性能量線硬化性組合物。而且,與實施例 1同樣地,將由活性能量線硬化性組合物之硬化物所組成稜鏡 部分形成於PET薄膜上,來製作稜鏡薄片。 (實施例11) 混合二苯酮〔BASF日本股份有限公司製,DAROCURE BP〕40份、以合成例4所得之胺基甲酸酯丙烯酸酯 份、丙烯酸苄酯〔曰立化成工業股份有限公司製,Fancryl FA-BZA〕35份及1-羥基-環己基-苯基-酮〔BASF日本股份有 限公司製’ Irgacure 184D〕4份,獲得活性能量線硬化性組合 物。而且,與實施例1同樣地,將由活性能量線硬化性組合物 之硬化物所組成稜鏡部分形成於PET薄膜上,來製作棱鏡薄 片。 (實施例12) 混合4_苯甲醯基4’-甲基二苯硫醚(双邦實業股份有限公 司製,SB-PI 705)25份、合成例8所得之丙烯酸環氧酯 (ΗΕΑ·2)25份、聚乙二醇二丙烯酸酯〔共榮社化學股份有限公 司製,輕丙烯酸酯3EG-A、環氧乙烷重複單位數3)50份及1_ 羥基-環己基-苯基-酮〔BASF日本股份有限公司製,irgacure 21 201211693 184D〕4份’獲得活性能量線硬化性組合物◊而且,與實施例 1同樣地,將由活性能量線硬化性組合物之硬化物所組成稜鏡 部分形成於PET薄膜上,來製作稜鏡薄片。 又,使用該活性能量線硬化性組合物來製作抗反射膜。亦 即,將該活性能量線硬化性組合物塗裝於PET薄膜,照射累 計光量300mJ/cm2之紫外線予以硬化,形成由其硬化物所組成 層(厚度ΙΟΟμηι)。接著,將混合〇pstarJM5010〔 JSR股份有限 公司製〕100份與1-羥基-環己基-苯基-酮〔BASF日本股份有 限公司製,Irgacure 184D〕0_3份而成之塗膜劑塗裝於由該硬 化物所組成層之上,照射累計光量400mJ/cm2之紫外線予以硬 化,形成低折射率層(厚度Ο.ίμιη),製成抗反射膜。 (實施例13) 混合二苯酮〔BASF日本股份有限公司製,DAROCURE BP〕25份、以合成例8所得之丙烯酸環氧酯(HEA-2)25份、 苯氧基聚乙二醇丙烯酸酯〔新中村化學工業股份有限公司製, NK酯AMP-10G,環氧乙烷重複單位數1〕50份及1-羥基-環 己基-苯基-酮〔BASF日本股份有限公司製,Irgacure 184D〕4 份’獲得活性能量線硬化性組合物。而且,與實施例1同樣地, 將由活性能量線硬化性組合物之硬化物所組成棱鏡部分形成 於PET薄膜上,來製作稜鏡薄片。 (實施例14) 混合4-曱基二苯酮〔大同化成工業股份有限公司製, DAIDO UV-CURE PMB〕25份、以合成例8所得之丙烯酸環 氧酯(HEA-2)25份、丙烯酸苄酯〔曰立化成工業股份有限公司 製,FancrylFA-BZA〕50份及1-羥基-環己基-苯基-酮〔BASF 日本股份有限公司製,Irgacure 184D〕4份,獲得活性能量線 硬化性組合物。而且,與實施例1同樣地,將由活性能量線硬 化性組合物之硬化物所組成稜鏡部分形成於PET薄膜上,來 製作棱鏡薄片。 (實施例15) 22 201211693 混合鄰苯甲醯基苯甲酸甲酯(双邦實業股份有限公司製, SB-PI 711)25份、以合成例8所得之丙烯酸環氧酯(HEA-2)25 份、丙烯酸鄰苯酚單乙氧酯〔曰本化藥股份有限公司製, KayaradOPP-l)50份及1-羥基-環己基-苯基-酮〔BASF日本股 份有限公司製,Irgacure 184D〕4份,獲得活性能量線硬化性 組合物。而且,與實施例1同樣地,將由活性能量線硬化性組 合物之硬化物所組成稜鏡部分形成於PET薄膜上,來製作稜 鏡薄片。 (實施例16) 混合二苯酮〔BASF日本股份有限公司製,DAROCURE BP〕15份、以合成例7所得之丙烯酸環氧酯(HEA-1)60份、 以合成例12所得之聚己内酯改性胺基甲酸酯丙烯酸酯 (UA_2)25份及1-羥基-環己基-苯基^〔BASF日本股份有限公 司製,Irgacurel84D〕4份,獲得活性能量線硬化性組合物。 而且,與實施例1同樣地’將由活性能量線硬化性組合物之硬 化物所組成稜鏡部分形成於PET薄膜上,來製作稜鏡薄片。 (實施例17) 混合二苯酮〔BASF曰本股份有限公司製,DAROCURE BP〕25份、以合成例6所得之胺基甲酸酯丙烯酸酯(Hua-3)50 份、以合成例2所得之聚己内酯改性胺基曱酸酯丙稀酸酯 (UA-1)25份及1-經基環己基-苯基-_〔BASF日本股份有限公 司製’ Irgacurel84D〕4份,獲得活性能量線硬化性組合物。 而且’與實施例1同樣地,將由活性能量線硬化性組合物之硬 化物所組成稜鏡部分形成於PET薄膜上,來製作稜鏡薄片。 又,使用該活性能量線硬化性組合物,來製作抗反射膜。 亦即,將活性能量線硬化性組合物塗裝於PET薄膜,照射累 計光量300mJ/cm2之紫外線予以硬化,形成由其硬化物所組成 層(厚度ΙΟΟμηι)。接著,將混合〇pStar JM5010〔 JSR股份有線 公司製〕100份與1-羥基-環己基-苯基-酮〔BASF曰本股份有 限公司製’Irgacure 184D〕0.3份而成之塗膜劑塗裝於由該硬 23 201211693 化物所組成層之上,照射累計光量4〇〇mj/cm2之紫外線予以硬 化,形成低折射率層(厚度Ο.ίμιη),製成抗反射膜。 (實施例18) /昆合一本酮〔BASF日本股份有限公司製,DAROCURE BP〕40份、以合成例9所得之丙烯酸環氧酯(HEA-3)35份、 以合成例14所得之聚己内酯改性胺基甲酸酯丙烯酸酯 (UA-4)25份及1·羥基-環己基-苯基·酮〔BASF日本股份有限公 司製,Irgacure 184D〕4份,獲得活性能量線硬化性組合物。 而且,與實施例1同樣地,將由活性能量線硬化性組合物之硬 化物所組成稜鏡部分形成於PET薄膜上,來製作稜鏡薄片。 (實施例19) 混合4-苯甲醯基-4’-甲基二苯硫醚(双邦實業股份有限公 司製,SB-PI 705)25份、以合成例1所得之胺基甲酸酯丙烯酸 酯(HUA-4)50份、以合成例15所得之聚己内酯改性胺基甲酸 西旨丙稀酸醋(UA-5)25份及1-經基-環己基-苯基-嗣〔 BASF曰本 股份有限公司製,Irgacure 184D〕4份’獲得活性能量線硬化 性組合物。接著’與實施例1同樣地,將由活性能量線硬化性 組合物之硬化物所組成稜鏡部分形成於PET薄膜上,來製作 棱鏡薄片。 (實施例20) 混合鄰苯甲醯基苯甲酸甲酯(双邦實業股份有限公司製, SB-PI 711)25份、以合成例5所得之胺基甲酸酯丙烯酸酯 (HUA-2)50份、以合成例13所得之聚己内酯改性胺基甲酸醋 丙烯酸酯(UA_3)25份及1-羥基-環己基-苯基-酮〔BASF曰本股 份有限公司製’ Irgacure 184D〕4份,獲得活性能量線硬化性 組合物。接著,與實施例1同樣地,將由活性能量線硬化性組 合物之硬化物所組成稜鏡部分形成於PET薄膜上,來製作稜 鏡薄片。 (實施例21)15 parts of mixed benzophenone (manufactured by BASF Japan Co., Ltd., DAROCURE 201211693 BP), dipentaerythritol hexaacrylate (manufactured by Shin-Nakamura Chemical Co., Ltd., NK ester A-DPH), 25 parts, acrylonitrile? Forty-six parts of "AcMO" (manufactured by Xingren Co., Ltd.) and 4 parts of 1-hydroxy-cyclohexyl-phenyl-net (manufactured by BASF Co., Ltd., Irgacure 184D) were used to obtain an active energy ray-curable composition. Further, in the same manner as in Example 1, a ruthenium portion composed of a cured product of the active energy ray-hardening composition was formed on a PET film to prepare a prism sheet. (Example 10) 25 parts of benzophenone (DAROCURE BP, manufactured by BASF Japan Co., Ltd.), 25 parts of epoxy acrylate (HEA-1) obtained in Synthesis Example 7, and propylene hydrazinoline Co., Ltd., ACMO] 50 parts and 1-ylidene-3⁄4 hexyl-benyl-oxime [manufactured by BASF Japan Co., Ltd., irgacure 184D] 4 parts to obtain an active energy ray-curable composition. Further, in the same manner as in Example 1, a ruthenium portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a ruthenium sheet. (Example 11) 40 parts of benzophenone (DAROCURE BP, manufactured by BASF Japan Co., Ltd.), urethane acrylate fraction obtained in Synthesis Example 4, and benzyl acrylate (manufactured by Toray Chemical Industry Co., Ltd.) 35 parts of Fancryl FA-BZA] and 4 parts of 1-hydroxy-cyclohexyl-phenyl-ketone [irgacure 184D by BASF Japan Co., Ltd.] were obtained to obtain an active energy ray-curable composition. Further, in the same manner as in Example 1, a ruthenium portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a prism sheet. (Example 12) 25 parts of 4_benzimidyl 4'-methyldiphenyl sulfide (SB-PI 705, manufactured by Shuangbang Industrial Co., Ltd.), and epoxy acrylate obtained in Synthesis Example 8 (ΗΕΑ· 2) 25 parts, polyethylene glycol diacrylate [manufactured by Kyoeisha Chemical Co., Ltd., light acrylate 3EG-A, ethylene oxide repeat unit number 3) 50 parts and 1_hydroxy-cyclohexyl-phenyl- Ketone (manufactured by BASF Japan Co., Ltd., irgacure 21 201211693 184D) 4 parts of 'enable active energy ray-curable composition ◊, and in the same manner as in Example 1, the cured product of the active energy ray-curable composition is composed of 酮Partially formed on a PET film to make a crucible sheet. Further, an antireflection film was produced using the active energy ray-curable composition. In other words, the active energy ray-curable composition is applied to a PET film, and is irradiated with ultraviolet rays having a cumulative light amount of 300 mJ/cm 2 to form a layer (thickness ΙΟΟμηι) composed of the cured product. Next, 100 parts of a mixture of 〇pstar JM5010 [manufactured by JSR Co., Ltd.] and 1-hydroxy-cyclohexyl-phenyl-ketone (manufactured by BASF Japan Co., Ltd., Irgacure 184D) was coated with a coating agent. On the layer composed of the cured product, ultraviolet rays having an integrated light amount of 400 mJ/cm 2 were irradiated to form a low refractive index layer (thickness Ο. ίμιη) to form an antireflection film. (Example 13) 25 parts of benzophenone (DAROCURE BP, manufactured by BASF Japan Co., Ltd.), 25 parts of epoxy acrylate (HEA-2) obtained in Synthesis Example 8, and phenoxy polyethylene glycol acrylate [New Nakamura Chemical Industry Co., Ltd., NK ester AMP-10G, ethylene oxide repeat unit number 1] 50 parts and 1-hydroxy-cyclohexyl-phenyl-ketone [BASF Japan Co., Ltd., Irgacure 184D] 4 parts 'Acquired active energy ray-curable composition. Further, in the same manner as in Example 1, a prism portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a ruthenium sheet. (Example 14) 25 parts of 4-isopropyl benzophenone (DAIDO UV-CURE PMB, manufactured by Datong Chemical Industry Co., Ltd.), 25 parts of epoxy acrylate (HEA-2) obtained in Synthesis Example 8, and acrylic acid were mixed. 50 parts of benzyl ester [Fancryl FA-BZA, manufactured by Toray Chemical Industry Co., Ltd.] and 4 parts of 1-hydroxy-cyclohexyl-phenyl-ketone (manufactured by BASF Japan Co., Ltd., Irgacure 184D), to obtain active energy ray hardenability combination. Further, in the same manner as in Example 1, a ruthenium portion composed of a cured product of the active energy ray-hardening composition was formed on a PET film to prepare a prism sheet. (Example 15) 22 201211693 25 parts of methyl phthalate benzoate (SB-PI 711, manufactured by Shuangbang Industrial Co., Ltd.), and epoxy acrylate (HEA-2) 25 obtained in Synthesis Example 8. 50 parts of butyl phenol monoethoxylate (Kayarad OPP-1, manufactured by Sakamoto Chemical Co., Ltd.) and 4-hydroxy-cyclohexyl-phenyl-ketone (manufactured by BASF Japan Co., Ltd., Irgacure 184D) 4 parts An active energy ray-curable composition is obtained. Further, in the same manner as in Example 1, a ruthenium portion composed of a cured product of an active energy ray-curable composition was formed on a PET film to prepare a prism sheet. (Example 16) 15 parts of benzophenone (DAROCURE BP, manufactured by BASF Japan Co., Ltd.), 60 parts of epoxy acrylate (HEA-1) obtained in Synthesis Example 7, and polycapone obtained in Synthesis Example 12 25 parts of ester-modified urethane acrylate (UA_2) and 4 parts of 1-hydroxy-cyclohexyl-phenyl^ (Irgacurel 84D, manufactured by BASF Japan Co., Ltd.) were obtained to obtain an active energy ray-curable composition. Further, in the same manner as in Example 1, a crucible portion composed of a hard material of the active energy ray-curable composition was formed on a PET film to prepare a crucible sheet. (Example 17) 25 parts of benzophenone (DAROCURE BP, manufactured by BASF Co., Ltd.) and 50 parts of urethane acrylate (Hua-3) obtained in Synthesis Example 6 were obtained in Synthesis Example 2. 25 parts of polycaprolactone-modified amino phthalate acrylate (UA-1) and 1-partyl 1-cyclohexyl-phenyl--[Argacurel 84D] manufactured by BASF Japan Co., Ltd. Energy line hardening composition. Further, in the same manner as in Example 1, a crucible portion composed of a hard material of the active energy ray-curable composition was formed on a PET film to prepare a crucible sheet. Further, an antireflection film was produced using the active energy ray-curable composition. In other words, the active energy ray-curable composition is applied to a PET film, and is irradiated with ultraviolet rays having a cumulative light amount of 300 mJ/cm 2 to form a layer (thickness ΙΟΟμηι) composed of the cured product. Next, 100 parts of a coating agent prepared by mixing 100 parts of 〇pStar JM5010 [manufactured by JSR Corporation) with 1-hydroxy-cyclohexyl-phenyl-ketone [Irgacure 184D manufactured by BASF Co., Ltd.] was applied. On the layer composed of the hard 23 201211693 compound, ultraviolet rays having an integrated light amount of 4 〇〇 mj/cm 2 were irradiated to form a low refractive index layer (thickness Ο. ίμιη) to prepare an antireflection film. (Example 18) 40 parts of a ketone (BASF Japan Co., Ltd., DAROCURE BP), 35 parts of an epoxy acrylate (HEA-3) obtained in Synthesis Example 9, and a polymerization obtained in Synthesis Example 14. 25 parts of caprolactone-modified urethane acrylate (UA-4) and 1 part of hydroxy-cyclohexyl-phenyl ketone (manufactured by BASF Japan Co., Ltd., Irgacure 184D), and obtained active energy ray hardening Composition. Further, in the same manner as in Example 1, a crucible portion composed of a hard material of the active energy ray-curable composition was formed on a PET film to prepare a crucible sheet. (Example 19) 25 parts of 4-benzylidene-4'-methyldiphenyl sulfide (SB-PI 705, manufactured by Shuangbang Industrial Co., Ltd.) was mixed with the urethane obtained in Synthesis Example 1. 50 parts of acrylate (HUA-4), 25 parts of polycaprolactone-modified carbamic acid modified urethane acetate (UA-5) obtained in Synthesis Example 15, and 1-trans-cyclohexyl-phenyl-嗣 [BASF 曰 股份有限公司, Irgacure 184D] 4 parts 'Acquired active energy ray-curable composition. Then, in the same manner as in Example 1, a ruthenium portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a prism sheet. (Example 20) 25 parts of methyl phthalate benzoate (SB-PI 711, manufactured by Shuangbang Industrial Co., Ltd.) and urethane acrylate (HUA-2) obtained in Synthesis Example 5 were mixed. 50 parts of 25 parts of polycaprolactone-modified urethane acrylate (UA_3) obtained in Synthesis Example 13 and 1-hydroxy-cyclohexyl-phenyl-ketone [IRgacure 184D by BASF Co., Ltd.] 4 parts, an active energy ray-curable composition was obtained. Then, in the same manner as in Example 1, a ruthenium portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a prism sheet. (Example 21)
混合二苯酮〔BASF日本股份有限公司製,DAROCURE 24 201211693 BP〕15份、丙烯_苯料乙械〔日本鋪股份有限公司 製’ Kayarad OPP-1〕70份、以合成例12所得之聚己内酯改性 胺基甲酸酯丙烯酸酯(UA-2)15份及1-羥基-環己基-苯基-酮 〔BASF日本股份有限公司製,irgacure 184D〕4份,獲得活 性能量線硬化性組合物。而且,與實施例丨同樣地,將由活性 月包置線硬化性組合物之硬化物所組成棱鏡部分形成於PET薄 膜上,來製作稜鏡薄片。 、 (實施例22) 混合二苯酮〔BASF日本股份有限公司製’ BP〕25份、本氧基聚乙二醇丙晞酸醋〔新中村化學工業股份 有限公司製,NK酯AMP-10G,環氧乙烷重複單位數丨〕60 份、以合成例2所得之聚己内酯改性胺基甲酸酯丙烯酸酯 (UA-1)15伤及1-經基-環己基-苯基__〔BASF日本股份有限公 司製’ Irgacure 18ffi〕4份,獲得活性能量線硬化性組合物。 而且’與實施例1同樣地’將由活性能量線硬化性組合物之硬 化物所組成稜鏡部分形成於PET薄膜上,來製作稜鏡薄片。 又,使用該活性能量線硬化性組合物,來製作抗反射膜。 亦即,將活性能量線硬化性組合物塗裝於PET薄膜,照射累 計光量300mJ/cm2之紫外線予以硬化,形成由其硬化物所組成 層(厚度ΙΟΟμηι)。接著,將混合0pstar剔5〇1〇〔 JSR股份有線 公司製〕100份與1-羥基-環己基-苯基-酮〔BASF日本股份有 限公司製,Irgacure 184D〕0.3份而成之塗膜劑塗裝於由該硬 化物所組成層之上’照射累計光量4〇〇mJ/cm2之紫外線予以硬 化,形成低折射率層(厚度Ο.ίμιη),製成抗反射膜。 (實施例23) 混合二苯酮〔BASF曰本股份有限公司製,DAROCURE BP〕40份、丙烯酸节醋〔日立化成工業股份有限公司製,Fancryl FA-BZA〕45份、以合成例14所得之聚己内酯改性胺基甲酸 酯丙烯酸醋(UA-4)15份及1-羥基-環己基-苯基·酮〔BASf曰本 股份有限公司製,Irgacure 184D〕4份,獲得活性能量線硬化 25 201211693 性組合物。而且’與實施例1同樣地,將由活性能量線硬化性 組合物之硬化物所組成稜鏡部分形成於PET薄膜上,來製作 稜鏡薄片。 (實施例24) 混合4-苯甲醯基-4’-曱基二苯硫醚〔双邦實業股份有限公 司製,SB-PI705)25份、丙烯酸鄰苯酚單乙氧酯〔日本化藥股 份有限公司製,Kayarad OPP-1〕60份、以合成例13所得之聚 己内酯改性胺基甲酸酯丙烯酸酯(UA-3)15份、1-羥基-環己基-苯基-酮〔BASF日本股份有限公司製,irgacure 184D〕4份, 獲得活性能量線硬化性組合物。而且,與實施例1同樣地,將 由活性能量線硬化性組合物之硬化物所組成棱鏡部分形成於 PET薄膜上,來製作稜鏡薄片。 (實施例25) 混合二苯酮〔BASF曰本股份有限公司製,DAROCURE BP〕15份、雙酚A型EO改性二丙烯酸酯〔日本化藥股份有 限公司製,Kayarad R-551 ’環氧乙烷合計加成4莫耳〕20份、 丙烯醯基嗎福啉〔興人股份有限公司製,ACMO〕45份、以 合成例13所得之聚己内酯改性胺基甲酸酯丙烯酸酯(ua-3)20 份及1-羥基-環己基-苯基-酮〔BASF日本股份有限公司製, Irgacure 184D〕4份’獲得活性能量線硬化性組合物。而且, 與實施例1同樣地’將由活性能量線硬化性組合物之硬化物所 組成棱鏡部分形成於PET薄膜上,來製作稜鏡薄片。 (實施例26) 混合二苯酮〔BASF日本股份有限公司製,DAROCURE BP〕25份、以合成例6所得之胺基甲酸酯丙烯酸酯(HUA-3)20 份、苯氧基聚乙二醇丙晞酸酯〔新中村化學工業股份有限公司 製’ NK酯AMP-10G,環氧乙烷重複單位數1〕45份、以合 成例2所得之聚己内酯改性胺基曱酸酯丙烯酸酯(υΑ^)^份 及1-經基-環己基-苯基-酮〔BASF曰本股份有限公司製, Irgacurel84D〕4份’獲得活性能量線硬化性組合物^接著, 26 201211693 .與實施例1同樣地,將由活性能量線硬化性組合物之硬化物所 組成稜鏡部分形成於PET薄膜上’來製作稜鏡薄片。 (實施例27) 混合二苯酮〔BASF日本股份有限公司製,dar〇cure BP〕40份、以合成例1所得之胺基甲酸酯丙烯酸酯(HUA-4)10 份、丙烯酸苄酯〔日立化成工業股份有限公司製,Fancryl FA-BZA〕40份、以合成例12所得之聚己内酯改性胺基甲酸 酉旨丙婦酸I旨(UA-2) 10份及1-經基-環己基-苯基-酿j〔 BASF曰本 股份有限公司製,Irgacurel84D〕4份,獲得活性能量線硬化 性組合物。接著,與實施例1同樣地,將由活性能量線硬化性 組合物之硬化物所組成稜鏡部分形成於PET薄膜上,來製作 棱鏡薄片。 (實施例28) 混合4-甲基二苯酮〔大同化成工業股份有限公司製, DAIDO UV-CURE PMB〕25份、以合成例8所得之丙烯酸環 氧酯(HEA-2)20份、丙烯酸鄰苯酚單乙氧酯〔曰本化藥股份有 限公司製’ Kayarad OPP-1〕45份、以合成例2所得之聚己内 酯改性胺基甲酸酯丙烯酸酯(UA-1)10份及1-羥基·環己基-苯 基-酮〔BASF日本股份有限公司製,irgacurel84D〕4份,獲 得活性能量線硬化性組合物。接著,與實施例1同樣地,將由 活性能量線硬化性組合物之硬化物所組成棱鏡部分形成於 PET薄膜上,來製作稜鏡薄片。 又,使用該活性能量線硬化性組合物來製作抗反射膜。亦 即’將活性能量線硬化性組合物塗裝於PET薄膜,照射累計 光量300mJ/cm2之紫外線予以硬化,並形成由其硬化物所組成 層(厚度ΙΟΟμηι)。接著,將混合Opstar JM5010〔 JSR股份有線 公司製〕100份與1_羥基-環己基-苯基-酮〔BASF日本股份有 限公司製,Irgacure 184D〕0.3份而成之塗膜劑塗裝於由該硬 化物所組成層之上,照射累計光量4〇〇mj/cm2之紫外線予以硬 化’形成低折射率層(厚度01μιη),製成抗反射膜。 27 201211693 (實施例29) 混合鄰苯甲醯基苯甲酸甲酯(双邦實業股份有限公司製, SB-PI 711)25份、以合成例1〇所得之丙烯酸環氧醋(ηεα·4)2〇 份、丙烯酸鄰苯酚單乙氧酯〔日本化藥股份有限公司製, Kayarad ΟΡΡ-1〕45份、以合成例14所得之聚己内酯改性胺基 甲酸醋丙烯酸酯(UA-4)10份及1·經基-環己基-苯基_酮〔BASf 曰本股份有限公司製,Irgacure 184D〕4份,獲得活性能量線 硬化性組合物。而且,與實施例1同樣地,將由活性能量線硬 化性組合物之硬化物所組成稜鏡部分形成於PET薄膜上,來 製作稜鏡薄片。 ' 又,使用該活性能量線硬化性組合物來製作抗反射膜。亦 即,將活性能量線硬化性組合物塗裝於PET薄膜,照射累計 光量300mJ/cm2之紫外線予以硬化,並形成由其硬化物所組成 層(厚度ΙΟΟμιη)。接著,將混合Opstar JM5010〔 JSR股份有限 公司製〕100份與1-經基-環己基-苯基-酮〔BASF日本股份有 限公司製,Irgacure 184D〕0.3份而成之塗膜劑塗裝於由該硬 化物所組成層之上’照射累計光量400mJ/cm2之紫外線予以硬 化’形成低折射率層(厚度0·1μτη),製成抗反射膜。 (實施例30) 混合4-苯甲醯基4’-甲基二苯硫_(双邦實業股份有限公 司製,SB-PI 705)25份、以合成例1所得之胺基甲酸酯丙烯酸 酯(HUA-4)20份、丙烯酸鄰苯酚單乙氧酯〔曰本化藥股份有限 公司製’ Kayarad OPP-1〕45份、以合成例15所得之聚己内酯 改性胺基曱酸酯丙烯酸酯(UA-5)10份及1-羥基-環己基-苯基_ 酮〔BASF日本股份有限公司製,Irgacure 184D〕4份,獲得 活性能量線硬化性組合物。而且,與實施例1同樣地,將由活 性能量線硬化性組合物之硬化物所組成棱鏡部分形成於PET 薄膜上,來製作稜鏡薄片。 (實施例31)15 parts of benzophenone (manufactured by BASF Japan Co., Ltd., DAROCURE 24 201211693 BP), 70 parts of propylene-benzene material [Kayarad OPP-1 manufactured by Nippon Kasei Co., Ltd.), and polycondensation obtained in Synthesis Example 12. 15 parts of lactone-modified urethane acrylate (UA-2) and 4 parts of 1-hydroxy-cyclohexyl-phenyl-ketone (manufactured by BASF Japan Co., Ltd., irgacure 184D) to obtain active energy ray hardenability combination. Further, in the same manner as in Example 棱镜, a prism portion composed of a cured product of the active reticle-curable composition was formed on a PET film to prepare a ruthenium sheet. (Example 22) 25 parts of benzophenone [BASF Japan Co., Ltd. 'BP], this oxy polyethylene glycol propylene glycol vinegar [Nippon Nakamura Chemical Industry Co., Ltd., NK ester AMP-10G, Ethylene oxide repeating unit number 丨] 60 parts, polycaprolactone-modified urethane acrylate (UA-1) 15 obtained in Synthesis Example 2 was injured with 1-carbyl-cyclohexyl-phenyl group 4 parts of 'IRgacure 18ffi' manufactured by BASF Japan Co., Ltd.) to obtain an active energy ray-curable composition. Further, in the same manner as in Example 1, a crucible portion composed of a hard material of the active energy ray-curable composition was formed on a PET film to prepare a crucible sheet. Further, an antireflection film was produced using the active energy ray-curable composition. In other words, the active energy ray-curable composition is applied to a PET film, and is irradiated with ultraviolet rays having a cumulative light amount of 300 mJ/cm 2 to form a layer (thickness ΙΟΟμηι) composed of the cured product. Next, a mixture of 100 parts of 0pstar and 5〇1〇 [manufactured by JSR Co., Ltd.] and 0.3 parts of 1-hydroxy-cyclohexyl-phenyl-ketone (manufactured by BASF Japan Co., Ltd., Irgacure 184D) was mixed. The ultraviolet light irradiated with a cumulative light amount of 4 〇〇 mJ/cm 2 on the layer composed of the cured product is cured to form a low refractive index layer (thickness Ο. ίμιη) to form an antireflection film. (Example 23) 40 parts of benzophenone (manufactured by BASF Co., Ltd., DAROCURE BP) and 45 parts of acrylic vinegar (Fancryl FA-BZA, manufactured by Hitachi Chemical Co., Ltd.) were mixed with Synthesis Example 14. 15 parts of polycaprolactone-modified urethane acrylate (UA-4) and 4 parts of 1-hydroxy-cyclohexyl-phenyl ketone [manufactured by BASf Co., Ltd., Irgacure 184D] to obtain active energy Line hardening 25 201211693 Sex composition. Further, in the same manner as in Example 1, a crucible portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a crucible sheet. (Example 24) 25 parts of 4-benzylidene-4'-mercaptodiphenyl sulfide (SB-PI705, manufactured by Shuangbang Industrial Co., Ltd.), butyl phenol monoethoxylate (Nippon Chemical Co., Ltd.) Co., Ltd., Kayarad OPP-1] 60 parts, 15 parts of polycaprolactone-modified urethane acrylate (UA-3) obtained in Synthesis Example 13, 1-hydroxy-cyclohexyl-phenyl-ketone 4 parts of [BASF Japan Co., Ltd., irgacure 184D], an active energy ray-curable composition was obtained. Further, in the same manner as in Example 1, a prism portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a ruthenium sheet. (Example 25) 15 parts of benzophenone (DAROCURE BP, manufactured by BASF Co., Ltd.), bisphenol A type EO modified diacrylate (Kayarad R-551 'epoxy, manufactured by Nippon Kayaku Co., Ltd.) 20 parts of ethane total addition of 4 moles, propylene decyl porphyrin (made by Xingren Co., Ltd., ACMO) 45 parts, polycaprolactone-modified urethane acrylate obtained in Synthesis Example 13 (ua-3) 20 parts and 1-hydroxy-cyclohexyl-phenyl-ketone (manufactured by BASF Japan Co., Ltd., Irgacure 184D) 4 parts to obtain an active energy ray-curable composition. Further, in the same manner as in Example 1, a prism portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a ruthenium sheet. (Example 26) 25 parts of benzophenone (DAROCURE BP, manufactured by BASF Japan Co., Ltd.), 20 parts of urethane acrylate (HUA-3) obtained in Synthesis Example 6, and phenoxy polyethylene Alcohol propionate [Nippon Nakamura Chemical Co., Ltd. 'NK ester AMP-10G, ethylene oxide repeat unit number 1] 45 parts, polycaprolactone modified amino phthalate obtained in Synthesis Example 2 Acrylate (υΑ^)^ and 1-trans-cyclohexyl-phenyl-ketone [manufactured by BASF Co., Ltd., Irgacurel 84D] 4 parts to obtain active energy ray-curable composition ^ Next, 26 201211693 . In the same manner as in Example 1, a crucible sheet was formed by forming a crucible portion composed of a cured product of an active energy ray-curable composition on a PET film. (Example 27) 40 parts of benzophenone (manufactured by BASF Japan Co., Ltd., dar〇cure BP), 10 parts of urethane acrylate (HUA-4) obtained in Synthesis Example 1, and benzyl acrylate [ 40 parts of Fancryl FA-BZA, manufactured by Hitachi Chemical Co., Ltd., and polycaprolactone-modified carbamic acid methacrylate obtained by Synthesis Example 12, propylene glycol I (UA-2) 10 parts and 1-base group - 4 parts of cyclohexyl-phenyl-brown (manufactured by BASF Co., Ltd., Irgacurel 84D) to obtain an active energy ray-curable composition. Then, in the same manner as in Example 1, a ruthenium portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a prism sheet. (Example 28) 25 parts of 4-methyl benzophenone (DAIDO UV-CURE PMB, manufactured by Datong Chemical Industry Co., Ltd.), 20 parts of epoxy acrylate (HEA-2) obtained in Synthesis Example 8, and acrylic acid were mixed. 45 parts of o-phenol monoethoxylate [Kayarad OPP-1] manufactured by Sakamoto Chemical Co., Ltd., and 10 parts of polycaprolactone-modified urethane acrylate (UA-1) obtained in Synthesis Example 2 Further, 4 parts of 1-hydroxycyclohexyl-phenyl-ketone (manufactured by BASF Japan Co., Ltd., irgacurel 84D) was obtained to obtain an active energy ray-curable composition. Then, in the same manner as in Example 1, a prism portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a ruthenium sheet. Further, an antireflection film was produced using the active energy ray-curable composition. That is, the active energy ray-curable composition is applied to a PET film, and is irradiated with ultraviolet rays having an integrated light amount of 300 mJ/cm 2 to form a layer (thickness ΙΟΟ μηι) composed of the cured product. Next, a coating agent prepared by mixing 100 parts of Opstar JM5010 [manufactured by JSR Co., Ltd.] and 0.3 parts of 1-hydroxy-cyclohexyl-phenyl-ketone (manufactured by BASF Japan Co., Ltd., Irgacure 184D) was coated with On the layer composed of the cured product, ultraviolet rays having an integrated light amount of 4 〇〇mj/cm 2 were irradiated to form a low refractive index layer (thickness: 01 μm) to form an antireflection film. 27 201211693 (Example 29) 25 parts of methyl phthalate benzoate (SB-PI 711, manufactured by Shuangbang Industrial Co., Ltd.) and acrylic acetal (ηεα·4) obtained in Synthesis Example 1 2 parts, 45 parts of acrylic acid o-phenol monoethoxylate (Kayarad®-1, manufactured by Nippon Kayaku Co., Ltd.), and polycaprolactone-modified urethane acrylate (UA-4) obtained in Synthesis Example 14. 10 parts and 1 part of a keto-cyclohexyl-phenyl ketone [manufactured by BASf Co., Ltd., Irgacure 184D] were used to obtain an active energy ray-curable composition. Further, in the same manner as in Example 1, a crucible portion composed of a cured product of the active energy ray-hardening composition was formed on a PET film to prepare a crucible sheet. Further, an antireflection film was produced using the active energy ray-curable composition. In other words, the active energy ray-curable composition is applied to a PET film, and is cured by irradiation with ultraviolet rays having an integrated light amount of 300 mJ/cm 2 to form a layer (thickness ΙΟΟ μηη) composed of the cured product. Next, 100 parts of a mixture of Opstar JM5010 [manufactured by JSR Co., Ltd.] and 0.3 parts of 1-carbyl-cyclohexyl-phenyl-ketone [Irgacure 184D, manufactured by BASF Japan Co., Ltd.] was applied to the coating agent. The low-refractive-index layer (thickness 0·1μτη) was formed by forming an ultraviolet ray having an accumulated light amount of 400 mJ/cm 2 on the layer composed of the cured product to form an anti-reflection film. (Example 30) 25 parts of 4-benzylidene 4'-methyldiphenyl sulfide (manufactured by Shuangbang Industrial Co., Ltd., SB-PI 705) was mixed with the urethane acrylate obtained in Synthesis Example 1. 20 parts of ester (HUA-4), 45 parts of 'Kayarad OPP-1' manufactured by Sakamoto Chemical Co., Ltd., and the polycaprolactone-modified amine phthalic acid obtained in Synthesis Example 15 10 parts of ester acrylate (UA-5) and 4 parts of 1-hydroxy-cyclohexyl-phenyl ketone (manufactured by BASF Japan Co., Ltd., Irgacure 184D) were used to obtain an active energy ray-curable composition. Further, in the same manner as in Example 1, a prism portion composed of a cured product of the active amount wire-curable composition was formed on a PET film to prepare a ruthenium sheet. (Example 31)
混合二苯酮〔BASF日本股份有限公司製,DAROCURE 28 201211693 BP〕25份、以合成例11所得之甲基丙烯酸環氧酯(HEA-5)20 份、丙烯酸鄰苯酚單乙氧酯〔曰本化藥股份有限公司製, Kayarad OPP-1〕45份及合成例2所得之聚己内酯改性胺基甲 酸酯丙烯酸酯(UA-l)lO份,獲得活性能量線硬化性組合物。 接著,以加速電壓150keV照射輻射量5Mrad之電子束於活性 能量線硬化性組合物所得到之硬化物,將由硬化物所組成稜鏡 部分形成於PET薄膜上,來製作稜鏡薄片。 (比較例1) 混合二苯酮〔BASF曰本股份有限公司製,DAROCURE BP)43份及雙酚A型改性二丙烯酸酯〔日本化藥股份有限 公司製,Kayarad R-551,環氧乙烷合計加成4莫耳〕57份, 獲得硬化性組合物。接著,照射累計光量400mJ/cm2之紫外線 於該硬化性組合物,予以硬化,將由其硬化物所組成稜鏡部分 形成於PET薄膜上,來製作稜鏡薄片。 (比較例2) 混合二苯酮〔BASF曰本股份有限公司製,DAROCURE BP〕12份、三羥甲基丙烷EO改性三丙烯酸酯〔東亞合成股 份有限公司製,Aronics M-360、環氧乙烷合計加成6莫耳〕88 份及1-羥基-環己基-苯基-酮〔BASF日本股份有限公司製, Irgacure 184D〕4份,獲得活性能量線硬化性組合物。而且, 將由該活性能量線硬化性組合物之硬化物所組成棱鏡部分形 成於PET薄膜上,來製作稜鏡薄片。 以上實施例1至31及比較例1、2之硬化性組合物之組 成、硬化性組合物中二苯酮含量(質量%)及芳香環含量(質量 %)係如表5至表8所示。 表5至表8中所使用英文縮寫之意義如下述。25 parts of mixed benzophenone (manufactured by BASF Japan Co., Ltd., DAROCURE 28 201211693 BP), 20 parts of methacrylic acid epoxy ester (HEA-5) obtained in Synthesis Example 11, and acrylate phenol monoethoxylate [曰本45 parts of Kayarad OPP-1] and 10 parts of polycaprolactone-modified urethane acrylate (UA-1) obtained in Synthesis Example 2 were obtained to obtain an active energy ray-curable composition. Next, a cured product obtained by irradiating an electron beam of 5 Mrad in an active energy ray-curable composition with an acceleration voltage of 150 keV, and a ruthenium portion composed of a cured product were formed on a PET film to prepare a ruthenium sheet. (Comparative Example 1) 43 parts of benzophenone (DAROCURE BP, manufactured by BASF Co., Ltd.) and bisphenol A type modified diacrylate (Kayarad R-551, epoxy B, manufactured by Nippon Kayaku Co., Ltd.) 57 parts of a total of 4 moles of alkane were added to obtain a curable composition. Then, ultraviolet rays having an integrated light amount of 400 mJ/cm 2 were irradiated onto the curable composition to be cured, and a crucible portion composed of the cured product was formed on the PET film to prepare a crucible sheet. (Comparative Example 2) 12 parts of benzophenone (DAROCURE BP, manufactured by BASF Co., Ltd.), trimethylolpropane EO-modified triacrylate (manufactured by Toagosei Co., Ltd., Aronics M-360, epoxy) Ethylene was added in a total amount of 6 parts by weight, and 8 parts of 1-hydroxy-cyclohexyl-phenyl-ketone (manufactured by BASF Japan Co., Ltd., Irgacure 184D) was used to obtain an active energy ray-curable composition. Further, a prism portion composed of a cured product of the active energy ray-curable composition was formed on a PET film to prepare a ruthenium sheet. The composition of the curable composition of the above Examples 1 to 31 and Comparative Examples 1 and 2, the benzophenone content (% by mass) and the aromatic ring content (% by mass) in the curable composition are shown in Tables 5 to 8. . The meanings of the English abbreviations used in Tables 5 to 8 are as follows.
BzPh :二苯酮〔BASF曰本股份有限公司製,DAROCURE BP〕 4M-BzPh : 4-甲基二苯酮〔大同化成工業股份有限公司 製,DAIDO UV-CURE PMB〕 29 201211693 製:二笨甲酿基苯甲酸㈣双邦實業股份有限公司 BMS · 4-笨甲酿基-4’-甲基二苯硫醚(4_benz〇yi_4,_methyi diphenyl sulphide)(双邦實業股份有限公司製,SB pi7〇5)BzPh: benzophenone (DAROCURE BP, manufactured by BASF Co., Ltd.) 4M-BzPh: 4-methylbenzophenone (DAIDO UV-CURE PMB, manufactured by Datong Chemical Industry Co., Ltd.) 29 201211693 System: 2 Styrene benzoic acid (4) Shuangbang Industrial Co., Ltd. BMS · 4-stupyl-4'-methyldiphenyl sulfide (4_benz〇yi_4, _methyi diphenyl sulphide) (Shuangbang Industrial Co., Ltd., SB pi7〇 5)
BisA-DA :雙酚A型EO改性二丙烯酸酯〔日本化藥股份 有限公司製,KayamdR-551〕 ' DPHA:六丙烯酸二新戊四醇酯〔新中村化學工業股份有 限公司製,NK酯A-DPH〕 八 EO-TMPTA :三羥甲基丙烷EO改性三丙烯酸酯〔東亞合 成股份有限公司製,AronicsM-360,環氧乙烷合計加成6莫耳〕 PEG-DA3 :聚乙二醇二丙烯酸酉旨〔共榮社化學股份‘限 公司製,輕丙烯酸酯3EG-A,環氧乙烷重複單位數3〕 ACMO :丙烯醯基嗎福琳〔興人股份有限公司製,ACMO〕 PPEG-A1 :丙烯酸苯氧基乙酯〔新中村化學工業股份有限 公司製,AMP_10G,環氧乙烷重複單位數1〕 BZ-A :丙烯酸苄酯〔曰立化成工業股份有限公司製, Fancryl FA-BZA ] ΟΡΡ-A:丙烯酸鄰苯酚單乙氧醋〔曰本化藥股份有限公司 製,OPP-1〕 HDI:二異氰酸六亞甲酯〔東京化成工業股份有限公司製〕 【表5】 實施例 1 實施例 2 實施例 3 實施例 4 實施例 5 實施例 6 實施例 7 實施例 8 實施例 9 實施例 10 BzPh 15 25 40 - - - - 25 15 25 4M-BzPh • - 25 - - - OBM - - - 25 - - - BMS - - - 25 - - 25 - - AcB-1 - 158 - - - BisA-DA - - 60 - - - - - - - DPHA - - - - - - 25 - EO-TMPTA 85 - - - - - 30 201211693 HUA-3 - 75 - 琴 75 75 75 - - - HEA-1 - - 25 HEA-3 75 - - ACMO - 60 50 HDI - - - 4.9 - - - - 光聚合 引發劑 4 4 4 - 4 4 4 4 4 4 BzPh 含量 (質量%) 14.4 24.0 38.5 23.8 24.0 24.0 24.0 24.0 14.4 24.0 芳香環 含量 (質量%) 13.7 48.7 51.5 49.2 46.9 43.5 46.3 46.7 13.7 27.2 【表6】 實施例 11 實施例 12 實施例 13 實施例 14 實施例 15 實施例 16 實施例 17 實施例 18 實施例 19 實施例 20 BzPh 40 - 25 - - 15 25 40 - 琴 4M-BzPh - - - 25 - - - - 琴 OBM - - - - 25 - - - - 25 BMS - 25 - - - - - - 25 - HUA-1 25 - HUA-2 - - - - - - - - - 50 HUA-3 - - - - - - 50 - - - HUA-4 - 50 - HEA-1 - - - - - 60 - - - - HEA-2 - 25 25 25 25 - - - - - HEA-3 35 PEG-DA3 - 50 - PPEG-A1 50 - - - - - - - BZ-A 35 - - 50 - - - - - - OPP-A - - - - 50 - - - - UA-1 25 - - - UA-2 - - - - 25 - - - UA-3 25 UA-4 - - - - - - 25 - - UA-5 25 - 31 201211693 光聚合 引發劑 4 4 4 4 4 4 4 4 4 4 BzPh 含量 (質量%) 38.5 24.0 24.0 24.0 24.0 14.4 24.0 38.5 24.0 24.0 芳香環 含量 (質量%) 56.3 27.3 49.0 50.8 52.0 26.5 39.7 49.5 45.6 34.2 【表7】 實施例 21 實施例 22 實施例 23 實施例 24 實施例 25 實施例 26 實施例 27 實施例 28 實施例 29 實施例 30 BzPh 15 25 40 雄 15 25 40 - - 4M-BzPh - - - - - - - 25 - - OBM 25 - BMS - 25 - - 25 BisA-DA - - 20 - - - - - HUA-3 - - - - 20 - - - - HUA-4 10 - - 20 HEA-2 - - - - - - 琴 20 - - HEA-4 - 20 _ ACMO _ - - - 45 - - PPEG-A1 - 60 - - - 45 - - - - BZ-A - - 45 - - - 40 - - - OPP-A 70 - - 60 - - - 45 45 45 UA-1 - 15 - - - 10 - 10 - - UA-2 15 墨 - - - - 10 - - - UA-3 - - - 15 20 - - UA-4 - - 15 - - 10 - UA-5 - 10 光聚合 引發劑 4 4 4 4 4 4 4 4 4 4 BzPh 含量 (質量%) 14.4 24.0 38.5 24.0 14.4 24.0 38.5 24.0 24.0 24.0 芳香環 含量 (質量%) 52.2 45.0 57.0 52.5 19.5 46.4 56.7 51.1 53.0 54.7 32 201211693 【表8】 實施例31 比較例1 比較例2 BzPh 25 43 12 BisA-DA 編 57 EO-TMPTA - • 88 HEA-5 20 ------ 〜-— - OPP-A 45 UA-1 10 _ 光聚合 引發劑 - 4 4 BzPh 含量 (質量%) 25.0 41.4 11.5 芳香環 含量 (質量%) 52.5 53.1 11.3 關於前述實施例i至31及比較例卜2之硬化性組合物, =下述所示讀綠啦生紐、祕性、硬化性、加工性、 耐不傷性、復原性及塗膜折射率。結果如表9至表12所示。 此外’表10至13中所使用之記號「〉」係小於之意。 <試驗方法> (1) 生產I生 在稜鏡部分形成時’硬化性組合物之硬化所需時間小於i 分鐘之物評價為0、1分鐘以上之物評價為△、未硬化之物評 價為X。 (2) 成形性 以顯微鏡觀察20mm見方之稜鏡薄片之稜鏡部分表面,與 稜鏡部分形成時使用的成形模具(shaping die)之形狀相比遍及 全體為相同形狀之物評價為〇、部分為相同形狀之物評價為 △、遍及全體為不同形狀之物評價為X。 (3) 硬化性 33 201211693 以手指感觸稜鏡部分之表面時無黏感(tack)(黏性)之物評 價為〇、有黏感之物評價為x。 ⑷加工性 在將稜鏡薄片纏繞於直徑2.5cm之圓筒時,在稜鏡部分不 產生龜裂或裂痕等損傷之物評價為〇、產生部分損傷之物評價 為△、遍及全體產生損傷之物評價為X。 (5)财擦傷性(mar-proof) 使用#000之鋼棉(steel wool),以50公克之負荷來回摩擦 (rubbing)lO次後,測定霧值(%)。 丁 ⑹復原性 以不銹鋼製之針將棱鏡薄片之稜鏡部分表面刮出損傷,測 定該相傷復原為止所需時間[s] ^ 、 (7)塗膜折射率 硬化塗膜之折射率係以阿倍折射計測定。 【表9】 實施例 1 實施例 2 實施例 3 實施例 4 實施例 5 實施例 6 實施例 7 實施例 8 實施例 9 實施例 10 生產性 〇 0 〇 Δ 〇 〇 〇 〇 〇 〇 成形性 Δ Δ Δ Δ Δ Δ Δ △ 〇 〇 硬化性 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 加工性 〇 0 〇 Δ 〇 〇 〇 〇 〇 〇 耐擦傷性 4.2 2.4 3.8 4.0 2.7 2.5 2.5 3.9 4.9 4.6 復原性 [S] 無法復 原 無法復 原 無法復 原 無法復 原 無法復 原 無法復 原 無法復 原 無法復 原 無法復 原 無法復 原 塗膜 折射率 1.525 1.590 1.578 1.580 1.588 1.586 1.598 1.589 1.537 1.556 【表10】 實施例 11 實施例 12 實施例 13 實施例 14 實施例 15 實施例 16 實施例 17 實施例 18 實施例 19 實施例 20 生產性 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 34 201211693 成形性 〇 〇 〇 〇 〇 Δ Δ Δ Δ Δ 硬化性 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 加工性 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 耐擦傷性 4.1 4.6 4.5 4.4 4.4 2.1 2> 2.2 2> 2> 復原性 [S] 無法復 原 無法復 原 無法復 原 無法復 原 無法復 原 60> 60> 60> 300> 300> 塗膜 折射率 1.580 1.550 1.574 1.581 1.597 1.547 1.570 1.584 1.599 1.563 【表η】 實施例 21 實施例 22 實施例 23 實施例 24 實施例 25 實施例 26 實施例 27 實施例 28 實施例 29 實施例 30 生產性 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 成形性 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 硬化性 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 加工性 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 耐擦傷性 4.0 3.5 3.2 3.4 2> 2> 2> 2> 2> 2> 復原性 [S] 10> 10> 10> 30> 30> 10> 10> 10> 10> 30> 塗膜 折射率 1.591 1.570 1.581 1.605 1.543 1.570 1.580 1.590 1.601 1.611 【表12】 實施例31 比較例1 比較例2 生產性 〇 〇 〇 成形性 〇 Δ Δ 硬化性 〇 X 〇 加工性 〇 〇 〇 耐擦傷性 2> 3.5 4.4 復原性 [s] 10> 無法復原 無法復原 塗膜 折射率 1.589 1.583 1.518 由表9至表12所示結果可知,在二苯酮或其衍生物含有 13至40質量%之實施例1至31之硬化性組合物之情形,可獲 35 201211693 得具有高折射率與優異耐擦傷性的硬化物。 又’由實施例1與比較例2之比較可知,硬化性化合物中 二苯酮之含量小於13質量%,則無法獲得充分的塗膜折射率。 由實施例3與比較例1之比較可知,若二苯酮之含量超過4〇 質量%時,則產生硬化性組合物之硬化不良。由實施例2與實 施例4之比較可知’相較於加熱硬化性組合物,以活性能量線 硬化性組合物之生產性較良好。由實施例2、5至7之比較可 知,在二苯酮及其衍生物中使用4-苯甲醯基-4,甲基二苯硫醚 (英文縮寫BMS)之情形’折射率最高’接著是二苯酮。 由實施例2與實施例8之比較可知,耐擦傷性相較於丙晞 酸環氧酯’以胺基甲酸酯丙烯酸酯較為良好。由實施例1〇、 13至15之比較可知’在硬化性化合物中芳香環含量為3〇質 量%以上之情形’塗膜折射率為1·56以上較高,其中在使用丙 烯酸苄酯及丙烯酸鄰苯基酚單乙氧基酯之情形,則塗膜折射率 1.58以上為特高。由實施例1至8與實施例9至15之比較及 實施例16至20與實施例25至30之比較顯然可知,稀釋單體 (PEG-DA3、ACMO、PPEG-A卜 ΒΖ-Α 及 ΟΡΡ-Α)之導入可使 成形性提高。 由實施例1至8與實施例16至20之比較可知,以聚己内 酯改性胺基甲酸酯丙烯酸酯(UA-1至UA-5)之導入顯現損傷之 復原性,又,亦可提高耐擦傷性。由比較實施例21至24與實 施例26至30可判明,胺基甲酸酯丙烯酸酯(HUA-3、HUA-4) 及丙烯酸環氧酯(ΗΕΑ-2、ΗΕΑ-4)之導入可提高耐擦傷性。由 實施例25至30之比較可知,不論聚己内酯改性胺基曱酸酯丙 烯酸酯之異氰酸酯之種類’财擦傷性或損傷之復原性大致被維 持。由實施例16至20之比較可知,相較於使用己内酯重複單 位數為1之己内酯改性丙烯酸羥乙酯所得之聚己内酯改性胺 基甲酸酯丙稀酸酯(UA-3、UA-5),以使用己内酯重複單位數 為2之己内酯改性丙烯酸羥乙酯所得之聚己内酯改性胺基甲 酸酯丙烯酸酯(UA-1、UA-4),或使用己内酯重複單位數為5 36 201211693 旨生丙稀酸經乙醋所得之聚己内醋改性胺基甲酸醋 丙婦㈣(UA-2)之情況,硬化物雜之復原性較快。 ”《•進:步可知,硬化性組合物中芳香環之含量為39質量% 以上之,形,塗膜折射率為1_57以上較高。 、 接著,關於使用該實施例4、12、17、22、28及29之硬 ,丨生、、’且σ物製作的抗反;^膜’係以下述所示方法測定平均反射 率二生產性、耐衝擊性、復原性及塗膜折射率。結果如3 所示。 <抗反射膜之評價項目> (平均反射率) 使用为光光度計測定波長450至650nm光之平均反射率 (0/〇)。 (生產性) 硬化性組合物之硬化所需時間小於1分鐘之物評價為oq 分鐘以上之物評價為△、不硬化之物評價為X。 (耐衝擊性) 使用杜邦式衝擊試驗機’以秤站碼(scale weight)之前端徑 1/4英吋、秤砝碼之重量5〇〇g、秤破碼之落下高度5〇cm之條 件下進行衝擊試驗。不產生龜裂或裂痕等損傷之物評價為〇、 產生部分損傷之物評價為△、遍及全體產生損傷之物評價為χ。 (復原性) 以不銹鋼製之針將硬化性組合物之硬化塗膜表面刮出損 傷’測定該損傷至復原為止所需時間[s]。 (塗膜折射率) 以阿倍折射計測定硬化性組合物之硬化塗膜折射率。 【表13】 實施例4 實施例12 實施例17 實施例22 實施例28 實施例29 平均反射率 1.58 1.68 1.61 1.63 1.55 1.51 生產性 Δ 〇 〇 〇 〇 〇BisA-DA: bisphenol A type EO modified diacrylate [KayamdR-551, manufactured by Nippon Kayaku Co., Ltd.] 'DPHA: dipentaerythritol hexaacrylate [manufactured by Shin-Nakamura Chemical Co., Ltd., NK ester A-DPH] Eight EO-TMPTA: Trimethylolpropane EO modified triacrylate [manufactured by Toagosei Co., Ltd., Aronics M-360, total ethylene oxide addition of 6 moles] PEG-DA3: Polyethylene Alcohol Diacrylate 酉 〔 共 共 共 共 共 共 共 共 共 共 , , , , , , 轻 轻 轻 轻 轻 轻 轻 轻 轻 轻 轻 轻 AC AC AC AC AC AC AC AC AC AC AC AC AC AC AC AC AC PPEG-A1: phenoxyethyl acrylate (manufactured by Shin-Nakamura Chemical Co., Ltd., AMP_10G, ethylene oxide repeat unit number 1) BZ-A: benzyl acrylate [manufactured by Yuli Chemical Industry Co., Ltd., Fancryl FA -BZA ] ΟΡΡ-A: Acrylic o-phenol monoethoxy vinegar [Opto Chemicals Co., Ltd., OPP-1] HDI: hexamethylene diisocyanate [manufactured by Tokyo Chemical Industry Co., Ltd.] [Table 5 Embodiment 1 Embodiment 2 Embodiment 3 Embodiment 4 Embodiment 5 Embodiment 6 Example 7 Example 8 Example 9 Example 10 BzPh 15 25 40 - - - - 25 15 25 4M-BzPh • - 25 - - - OBM - - - 25 - - - BMS - - - 25 - - 25 - - AcB-1 - 158 - - - BisA-DA - - 60 - - - - - - - DPHA - - - - - - 25 - EO-TMPTA 85 - - - - - 30 201211693 HUA-3 - 75 - Piano 75 75 75 - - - HEA-1 - - 25 HEA-3 75 - - ACMO - 60 50 HDI - - - 4.9 - - - - Photopolymerization initiator 4 4 4 - 4 4 4 4 4 4 BzPh Content (% by mass) 14.4 24.0 38.5 23.8 24.0 24.0 24.0 24.0 14.4 24.0 Aromatic ring content (% by mass) 13.7 48.7 51.5 49.2 46.9 43.5 46.3 46.7 13.7 27.2 [Table 6] Example 11 Example 12 Example 13 Example 14 Example 15 Example 16 Example 17 Embodiment 18 Embodiment 19 Embodiment 20 BzPh 40 - 25 - - 15 25 40 - Piano 4M-BzPh - - - 25 - - - - Piano OBM - - - - 25 - - - - 25 BMS - 25 - - - - - - 25 - HUA-1 25 - HUA-2 - - - - - - - - - 50 HUA-3 - - - - - - 50 - - - HUA-4 - 50 - HEA-1 - - - - - 60 - - - - HEA-2 - 25 25 25 25 - - - - - HEA-3 35 PEG-DA3 - 50 - PPEG-A1 50 - - - - - - - BZ-A 35 - - 50 - - - - - - OPP-A - - - - 50 - - - - UA- 1 25 - - - UA-2 - - - - 25 - - - UA-3 25 UA-4 - - - - - - 25 - - UA-5 25 - 31 201211693 Photopolymerization initiator 4 4 4 4 4 4 4 4 4 4 BzPh content (% by mass) 38.5 24.0 24.0 24.0 24.0 14.4 24.0 38.5 24.0 24.0 Aromatic ring content (% by mass) 56.3 27.3 49.0 50.8 52.0 26.5 39.7 49.5 45.6 34.2 [Table 7] Example 21 Example 22 Example 23 Implementation Example 24 Example 25 Example 26 Example 27 Example 28 Example 29 Example 30 BzPh 15 25 40 Male 15 25 40 - - 4M-BzPh - - - - - - - 25 - - OBM 25 - BMS - 25 - - 25 BisA-DA - - 20 - - - - - HUA-3 - - - - 20 - - - - HUA-4 10 - - 20 HEA-2 - - - - - - Piano 20 - - HEA-4 - 20 _ ACMO _ - - - 45 - - PPEG-A1 - 60 - - - 45 - - - - BZ-A - - 45 - - - 40 - - - OPP-A 70 - - 60 - - - 45 45 45 UA- 1 - 15 - - - 10 - 10 - - UA-2 15 Ink - - - - 10 - - - UA-3 - - - 15 20 - - UA-4 - - 15 - - 10 - UA-5 - 10 Photopolymerization initiator 4 4 4 4 4 4 4 4 4 4 BzPh Content (% by mass) 14.4 24.0 38.5 24.0 14.4 24.0 38.5 24.0 24.0 24.0 Aromatic ring content (% by mass) 52.2 45.0 57.0 52.5 19.5 46.4 56.7 51.1 53.0 54.7 32 201211693 [Table 8] Example 31 Comparative Example 1 Comparative Example 2 BzPh 25 43 12 BisA-DA Edited 57 EO-TMPTA - • 88 HEA -5 20 ------ ~-- - OPP-A 45 UA-1 10 _ Photopolymerization initiator - 4 4 BzPh Content (% by mass) 25.0 41.4 11.5 Aromatic ring content (% by mass) 52.5 53.1 11.3 About the foregoing The curable compositions of Examples i to 31 and Comparative Example 2 have the following readings, greenness, curability, workability, non-injury, restorability, and refractive index of the coating film. The results are shown in Tables 9 to 12. Further, the symbol "〉" used in the tables 10 to 13 is smaller than that. <Test method> (1) When the production of the bismuth portion is formed, the time required for the hardening of the sclerosing composition to be less than i minutes is evaluated as 0, and the content of the material is evaluated as Δ, uncured material. The evaluation is X. (2) Formability The surface of the enamel portion of the sheet of 20 mm square was observed under a microscope, and the shape of the shaping die used for forming the enamel portion was evaluated as 〇 and part of the same shape throughout the entire shape. The object of the same shape was evaluated as Δ, and the object of various shapes was evaluated as X. (3) Sturability 33 201211693 When the surface of the sputum is touched by the finger, the evaluation of the tack (stickiness) is 〇, and the stickiness is evaluated as x. (4) Machinability When the crucible sheet is wound around a cylinder having a diameter of 2.5 cm, the object which does not cause cracks or cracks in the crucible portion is evaluated as 〇, and the part which is partially damaged is evaluated as Δ, and damage is caused throughout the entire portion. The substance was evaluated as X. (5) Mar-proof After the rubbing of the steel wool of #000 was rubbed back and forth for 10 times with a load of 50 g, the haze value (%) was measured. D (6) Restoration The surface of the prism sheet is scraped off by a needle made of stainless steel, and the time required for the recovery of the phase damage is measured. [s] ^, (7) The refractive index of the coating film of the refractive index of the coating film is Abu refractometer measurement. [Table 9] Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Example 7 Example 8 Example 9 Example 10 Productivity 〇0 〇Δ 〇〇〇〇〇〇 Formability Δ Δ Δ Δ Δ Δ Δ △ 〇〇 hardenability 〇〇〇〇〇〇〇〇〇〇 processability 〇 0 〇 Δ 〇〇〇〇〇〇 scratch resistance 4.2 2.4 3.8 4.0 2.7 2.5 2.5 3.9 4.9 4.6 Resilience [S] Unrecoverable Unrecoverable Unrecoverable Unrecoverable Unrecoverable Unrecoverable Unrecoverable Unrecoverable Unrecoverable Unrecoverable Unrecoverable Coating Refractive Index 1.525 1.590 1.578 1.580 1.588 1.586 1.598 1.589 1.537 1.556 [Table 10] Example 11 Example 12 Example 13 Example 14 Example 15 Example 16 Example 17 Example 18 Example 19 Example 20 Productivity 〇〇〇〇〇〇〇〇〇〇34 201211693 Formability 〇〇〇〇〇Δ Δ Δ Δ Δ Hardenability 〇〇〇〇 〇〇〇〇〇〇Processability 〇〇〇〇〇〇〇〇〇〇Scratch resistance 4.1 4.6 4.5 4.4 4.4 2.1 2> 2.2 2>2> Resiliency [S] Unrecoverable Unrecoverable Unrecoverable Unrecoverable Unrecoverable Unrecoverable 60>60>60>300>300> Coating Refractive Index 1.580 1.550 1.574 1.581 1.597 1.547 1.570 1.584 1.599 1.563 [Table η] Example 21 Example 22 Example 23 Example 24 Example 25 Example 26 Example 27 Example 28 Example 29 Example 30 Productivity 〇〇〇〇〇〇〇〇〇〇 Formability 〇〇〇〇〇〇 〇〇〇〇Sturdy 〇〇〇〇〇〇〇〇〇〇Workability 〇〇〇〇〇〇〇〇〇〇Scratch resistance 4.0 3.5 3.2 3.4 2>2>2>2>2>2> Restoration [ S] 10 > 10 > 10 > 30 > 30 > 10 > 10 > 10 > 10 > 30 > Coating Film Refractive Index 1.591 1.570 1.581 1.605 1.543 1.570 1.580 1.590 1.601 1.611 [Table 12] Example 31 Comparative Example 1 Comparative Example 2 Production Sexual formability 〇Δ Δ Sturdy 〇X 〇Processability 〇〇〇Scratch resistance 2> 3.5 4.4 Restoration [s] 10> Unrecoverable Recovered Coating Film Refractive Index 1.589 1.583 1.518 From the results shown in Tables 9 to 12, it is understood that in the case where the benzophenone or its derivative contains 13 to 40% by mass of the curable composition of Examples 1 to 31, 35 is obtained. 201211693 A cured product with high refractive index and excellent scratch resistance. Further, from the comparison between Example 1 and Comparative Example 2, it is understood that when the content of the benzophenone in the curable compound is less than 13% by mass, a sufficient refractive index of the coating film cannot be obtained. As is clear from the comparison between Example 3 and Comparative Example 1, when the content of benzophenone exceeds 4% by mass, the curing of the curable composition is poor. From the comparison between Example 2 and Example 4, it was found that the productivity of the active energy ray-curable composition was better than that of the heat-curable composition. From the comparison of Examples 2, 5 to 7, it can be seen that the case of using 4-benzylidene-4,methyldiphenyl sulfide (BMS) in benzophenone and its derivatives is the highest refractive index. It is benzophenone. From the comparison between Example 2 and Example 8, it is understood that the scratch resistance is better than the urethane acrylate as the urethane acrylate. From the comparison of Examples 1 and 13 to 15, it can be seen that 'the aromatic ring content in the curable compound is 3% by mass or more', and the refractive index of the coating film is higher than 1.56 or higher, wherein benzyl acrylate and acrylic acid are used. In the case of o-phenylphenol monoethoxylate, the refractive index of the coating film is particularly high at 1.58 or more. From the comparison of Examples 1 to 8 with Examples 9 to 15 and the comparison of Examples 16 to 20 with Examples 25 to 30, it is apparent that the monomer (PEG-DA3, ACMO, PPEG-A, Α-Α and ΟΡΡ) are diluted. The introduction of -Α) improves the formability. From the comparison of Examples 1 to 8 and Examples 16 to 20, it is understood that the introduction of polycaprolactone-modified urethane acrylate (UA-1 to UA-5) exhibits the recovery of damage, and Improves scratch resistance. From Comparative Examples 21 to 24 and Examples 26 to 30, it was found that the introduction of urethane acrylate (HUA-3, HUA-4) and epoxy acrylate (ΗΕΑ-2, ΗΕΑ-4) can be improved. Scratch resistant. From the comparison of Examples 25 to 30, it is understood that the type of isocyanate of the polycaprolactone-modified amino phthalate acrylate has a substantial recovery from the scratch resistance or the damage. From the comparison of Examples 16 to 20, it is understood that the polycaprolactone-modified urethane acrylate obtained by repeating the caprolactone-modified hydroxyethyl acrylate of 1 in caprolactone ( UA-3, UA-5), polycaprolactone-modified urethane acrylate (UA-1, UA) obtained by using caprolactone-modified hydroxyethyl ester of caprolactone in 2 units of caprolactone -4), or the use of caprolactone repeat unit number is 5 36 201211693 The use of polyacrylic acid modified acetonitrile modified acetoacetate vinegar (4) (UA-2) It is more resilient. "Into the step: the content of the aromatic ring in the curable composition is 39% by mass or more, and the refractive index of the coating film is higher than 1_57. Next, regarding the use of the examples 4, 12, 17, 22, 28, and 29, hard, twin, and 'anti-reverse made of σ material; ^ film' was measured by the following method to determine the average reflectivity two productivity, impact resistance, restorability and coating film refractive index. The results are shown in 3. <Evaluation Item of Antireflection Film> (Average Reflectance) The average reflectance (0/〇) of light having a wavelength of 450 to 650 nm was measured by a photometer. (Productivity) Curable composition The object whose hardening time is less than 1 minute is evaluated as ω minutes or more, and the unhardened material is evaluated as X. (Impact resistance) The DuPont-type impact tester is used to measure the scale weight. The impact test is carried out under the condition that the front end diameter is 1/4 inch, the weight of the scale weight is 5 〇〇g, and the height of the scale is 5 〇cm. The damage that does not cause cracks or cracks is evaluated as 〇, and the part is produced. The damage is evaluated as △, and the damage caused by the whole is evaluated as χ. Properties: The surface of the cured coating film of the curable composition is scratched by a needle made of stainless steel. 'The time required for the damage to be recovered is measured [s]. (Refractive index of the coating film) The curable composition is measured by an ABC refractometer. Hardened coating film refractive index [Table 13] Example 4 Example 12 Example 17 Example 22 Example 28 Example 29 Average reflectance 1.58 1.68 1.61 1.63 1.55 1.51 Productivity Δ 〇〇〇〇〇
37 201211693 时衝擊性 Δ 〇 〇 〇 〇 〇 復原性 [S] 無法復原 無法復原 60> 10> 10> 10> 塗膜 折射率 1.580 1.550 1.570 1.570 1.590 1.601 由表13所示結果可知,使用實施例4、12、17、22、28 及29之硬化性組合物製作的抗反射膜均具有優異抗反射性 能’同時,具備良好的耐衝擊性。 此外,本實施形態可變更為其次方式實施。 •可組合複數種二苯酮或其衍生物使用。 •在硬化性組合物’可依照需要使光穩定劑、抗氧化劑、 抗靜電劑、密合性改良劑等混入。 •亦可將由硬化性組合物所得硬化物作為夫瑞乃(fresnel) 透鏡、薄片狀透鏡等使用。 關於可由該實施形態掌握的技術思想係如下述記載。 •如申請專利範圍第3項之硬化性組合物,其中該活性能 量線硬化性化合物含有:含芳香環30質量%以上且具有(甲基) 丙烯醯基之單體或寡聚物。在此情形,可使硬化物之折射率更 加提高。 •如申請專利範圍第3項之硬化性組合物,其中該活性能 量線硬化性化合物係丙烯酸苄酯或丙烯酸鄰苯酚單乙氧酯。在 此情形,可顯著提高硬化物之折射率。 •一種透鏡用塗膜劑,其係由如申請專利範圍第1項至第 5項中任一項記載之硬化性組合物所組成透鏡用塗膜劑,其係 塗布於透鏡表面使用。根據該透鏡用塗膜劑,提高透鏡之折射 率及提高透鏡表面之财擦傷性極為容易。 •一種抗反射薄膜,其係在薄片狀基材表面塗布如申請專 利範圍第1至5項中任一項之硬化性組合物,並形成硬化膜 後,在該硬化膜上形成抗反射膜所得者。該抗反射膜具有高折 射率與優異耐擦傷性。 〜 ° 38 201211693 【圖式簡單說明】 。 【主要元件符號說明】 無。37 201211693 Impact Δ 〇〇〇〇〇 Restoration [S] Unrecoverable Unrecoverable 60 > 10 > 10 >10> Coating Film Refractive Index 1.580 1.550 1.570 1.570 1.590 1.601 From the results shown in Table 13, it is known that Example 4 is used. The antireflection film made of the curable compositions of 12, 17, 22, 28 and 29 has excellent antireflection properties while having good impact resistance. Further, this embodiment can be implemented in a second embodiment. • Can be used in combination with multiple benzophenones or their derivatives. • A light stabilizer, an antioxidant, an antistatic agent, an adhesion improver, or the like may be mixed in the curable composition. • The cured product obtained from the curable composition may be used as a fresnel lens, a sheet lens, or the like. The technical idea that can be grasped by this embodiment is as follows. The curable composition according to claim 3, wherein the active energy ray-curable compound contains a monomer or oligomer having an aromatic ring of 30% by mass or more and having a (meth) acrylonitrile group. In this case, the refractive index of the hardened material can be further increased. The sclerosing composition according to claim 3, wherein the active energy ray curable compound is benzyl acrylate or phenol phenol monoethoxylate. In this case, the refractive index of the cured product can be remarkably increased. A coating agent for a lens comprising a coating agent for a lens comprising the curable composition according to any one of claims 1 to 5, which is applied to a surface of a lens. According to the lens coating agent, it is extremely easy to increase the refractive index of the lens and to improve the scratch resistance of the lens surface. An antireflection film obtained by coating a surface of a sheet-like substrate with a curable composition according to any one of claims 1 to 5, and forming a cured film, and then forming an antireflection film on the cured film. By. The antireflection film has high refractive index and excellent scratch resistance. ~ ° 38 201211693 [Simple description of the diagram]. [Main component symbol description] None.
3939
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010195673 | 2010-09-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201211693A true TW201211693A (en) | 2012-03-16 |
Family
ID=45772474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW100119169A TW201211693A (en) | 2010-09-01 | 2011-06-01 | Curable composition |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP4967076B2 (en) |
TW (1) | TW201211693A (en) |
WO (1) | WO2012029361A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110698642A (en) * | 2019-09-18 | 2020-01-17 | 江南大学 | Polyurethane modified epoxy acrylate resin and preparation method thereof |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5884988B2 (en) * | 2011-01-19 | 2016-03-15 | 日産化学工業株式会社 | High scratch-resistant imprint material containing urethane compound |
JP6565612B2 (en) * | 2015-11-05 | 2019-08-28 | 日油株式会社 | Active energy ray-curable resin composition |
WO2018174102A1 (en) * | 2017-03-23 | 2018-09-27 | 富士フイルム株式会社 | Curable composition for sheets, cured product and method for producing same, sheet for three-dimensional shaping, optical member, lenticular sheet and three-dimensional structure |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS594638A (en) * | 1982-06-30 | 1984-01-11 | Mitsubishi Plastics Ind Ltd | Film for label shrinkable at low temperature |
DE3447356A1 (en) * | 1984-12-24 | 1986-07-03 | Basf Ag, 6700 Ludwigshafen | LIGHT SENSITIVE RECORDING ELEMENT |
JP3580832B2 (en) * | 1992-08-27 | 2004-10-27 | 一方社油脂工業株式会社 | Aqueous emulsion type polymer UV absorber |
JP2010018797A (en) * | 2008-06-11 | 2010-01-28 | Sekisui Chem Co Ltd | Curable composition for optical parts, adhesive agent for optical parts, and sealing agent for organic electroluminescence element |
JP5717320B2 (en) * | 2009-03-12 | 2015-05-13 | リンテック株式会社 | Re-peelable adhesive sheet |
-
2011
- 2011-05-18 WO PCT/JP2011/061441 patent/WO2012029361A1/en active Application Filing
- 2011-05-18 JP JP2011547100A patent/JP4967076B2/en not_active Expired - Fee Related
- 2011-06-01 TW TW100119169A patent/TW201211693A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110698642A (en) * | 2019-09-18 | 2020-01-17 | 江南大学 | Polyurethane modified epoxy acrylate resin and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
JP4967076B2 (en) | 2012-07-04 |
WO2012029361A1 (en) | 2012-03-08 |
JPWO2012029361A1 (en) | 2013-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI482791B (en) | Urethane (metha) acrylate compound and resin composition containing such compound | |
TWI306884B (en) | ||
TWI551645B (en) | Radical-polymerizable composition, cured article and plastic lens | |
JP5641382B1 (en) | UV curable adhesive composition and adhesive | |
TW200911845A (en) | Urethane compound, curable composition containing the same, and cured product of the composition | |
JP5822052B1 (en) | UV-curable adhesive composition, adhesive film, and method for producing adhesive film | |
TW201105745A (en) | Energy beam curable resin composition and cured article thereof and optical lens | |
TW201245350A (en) | Active-energy-curable resin composition and coating agent | |
TW201250386A (en) | Energy ray-curable resin composition for optical lens sheet and cured product thereof, and the optical lens sheet | |
TW200906867A (en) | Energy ray-curable resin composition for optical lens sheet and cured product thereof | |
TW200906773A (en) | (Meth)acrylates, resin compositions containing the same, and products of curing of the compositions | |
JP6220600B2 (en) | Silicone part-containing urethane (meth) acrylate copolymer, composition and cured product thereof | |
TW201211693A (en) | Curable composition | |
JP6132140B2 (en) | UV curable adhesive composition and adhesive | |
WO2016002387A1 (en) | Ultraviolet ray-curable adhesive agent composition, adhesive film, and production method for adhesive film | |
TW201125883A (en) | Energy line curable resin composition and paint obtained using the composition | |
TWI635105B (en) | Photocurable resin composition, cured product thereof, and plastic lens | |
WO2015098307A1 (en) | Ultraviolet curable adhesive composition, adhesive film and method for producing adhesive film | |
JP5534606B2 (en) | Active energy ray-curable resin composition | |
JP6932900B2 (en) | Polyurethane (meth) acrylate and its composition, cured product | |
JP2019157092A (en) | Active energy ray-curable resin composition, and coating agent and sheet using the same | |
JP2017171891A (en) | Polyurethane (meth)acrylate, composition, cured article | |
JP6115284B2 (en) | UV curable adhesive composition and adhesive | |
JP5542011B2 (en) | Urethane group-containing (meth) acrylate resin composition | |
JP5056092B2 (en) | Tactile paint composition |